WO2008136889A1 - High spf transparent or translucent, cytoprotective, biodegradable, uv radiation resistant compositions - Google Patents
High spf transparent or translucent, cytoprotective, biodegradable, uv radiation resistant compositions Download PDFInfo
- Publication number
- WO2008136889A1 WO2008136889A1 PCT/US2008/003580 US2008003580W WO2008136889A1 WO 2008136889 A1 WO2008136889 A1 WO 2008136889A1 US 2008003580 W US2008003580 W US 2008003580W WO 2008136889 A1 WO2008136889 A1 WO 2008136889A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oil
- phase
- added
- minutes
- mixed
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 326
- 230000001120 cytoprotect Effects 0.000 title claims description 21
- 238000006065 biodegradation reaction Methods 0.000 title description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 161
- 239000003921 oil Substances 0.000 claims abstract description 157
- 235000019198 oils Nutrition 0.000 claims abstract description 156
- 239000000516 sunscreening agent Substances 0.000 claims abstract description 133
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 130
- 239000000843 powder Substances 0.000 claims abstract description 60
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 53
- 239000001993 wax Substances 0.000 claims abstract description 46
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 42
- 239000003240 coconut oil Substances 0.000 claims abstract description 39
- 235000019864 coconut oil Nutrition 0.000 claims abstract description 39
- 239000004005 microsphere Substances 0.000 claims abstract description 29
- 235000002961 Aloe barbadensis Nutrition 0.000 claims abstract description 27
- 240000005513 Aloe vera Species 0.000 claims abstract description 27
- 229940093504 ETHYL MACADAMIATE Drugs 0.000 claims abstract description 27
- 239000003974 emollient agent Substances 0.000 claims abstract description 27
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 27
- 239000011521 glass Substances 0.000 claims abstract description 24
- -1 silica compound Chemical class 0.000 claims abstract description 21
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 18
- 239000000341 volatile oil Substances 0.000 claims abstract description 18
- 239000002245 particle Substances 0.000 claims abstract description 14
- 239000000049 pigment Substances 0.000 claims abstract description 13
- 229910044991 metal oxide Inorganic materials 0.000 claims abstract description 12
- HWKQNAWCHQMZHK-UHFFFAOYSA-N Trolnitrate Chemical compound [O-][N+](=O)OCCN(CCO[N+]([O-])=O)CCO[N+]([O-])=O HWKQNAWCHQMZHK-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000000440 bentonite Substances 0.000 claims abstract description 9
- 229910000278 bentonite Inorganic materials 0.000 claims abstract description 9
- 150000004706 metal oxides Chemical class 0.000 claims abstract description 9
- 229920002545 silicone oil Polymers 0.000 claims abstract description 9
- 229920001525 carrageenan Polymers 0.000 claims abstract description 8
- 150000002148 esters Chemical class 0.000 claims abstract description 8
- 230000003000 nontoxic Effects 0.000 claims abstract description 6
- 231100000252 nontoxic Toxicity 0.000 claims abstract description 6
- 239000002562 thickening agent Substances 0.000 claims abstract description 6
- 239000002023 wood Substances 0.000 claims abstract description 6
- 239000008213 purified water Substances 0.000 claims abstract description 4
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 4
- 239000000230 xanthan gum Substances 0.000 claims abstract description 4
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 4
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 4
- 102000011782 Keratins Human genes 0.000 claims abstract description 3
- 108010076876 Keratins Proteins 0.000 claims abstract description 3
- 239000002105 nanoparticle Substances 0.000 claims abstract description 3
- 150000003904 phospholipids Chemical class 0.000 claims abstract 7
- 241000544019 Stratiotes aloides Species 0.000 claims abstract 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract 4
- 239000004927 clay Substances 0.000 claims abstract 3
- 229910052570 clay Inorganic materials 0.000 claims abstract 3
- 229920001661 Chitosan Polymers 0.000 claims abstract 2
- 235000015155 buttermilk Nutrition 0.000 claims abstract 2
- 238000004821 distillation Methods 0.000 claims abstract 2
- 230000001804 emulsifying Effects 0.000 claims abstract 2
- 239000002502 liposome Substances 0.000 claims abstract 2
- 238000006385 ozonation reaction Methods 0.000 claims abstract 2
- 238000002156 mixing Methods 0.000 claims description 123
- XLOMVQKBTHCTTD-UHFFFAOYSA-N zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 110
- 241001116389 Aloe Species 0.000 claims description 105
- 210000003491 Skin Anatomy 0.000 claims description 83
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 82
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 81
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 76
- 239000011787 zinc oxide Substances 0.000 claims description 55
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 48
- 235000011187 glycerol Nutrition 0.000 claims description 48
- 240000003497 Rubus idaeus Species 0.000 claims description 42
- 229960002747 Betacarotene Drugs 0.000 claims description 40
- 235000021355 Stearic acid Nutrition 0.000 claims description 40
- OENHQHLEOONYIE-VYAWBVGESA-N beta-Carotene Natural products CC=1CCCC(C)(C)C=1\C=C\C(\C)=C/C=C/C(/C)=C\C=C\C=C(\C)/C=C/C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-VYAWBVGESA-N 0.000 claims description 40
- 235000013734 beta-carotene Nutrition 0.000 claims description 40
- 239000011648 beta-carotene Substances 0.000 claims description 40
- 239000008117 stearic acid Substances 0.000 claims description 40
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 40
- 235000019774 Rice Bran oil Nutrition 0.000 claims description 39
- 235000013871 bee wax Nutrition 0.000 claims description 39
- 239000012166 beeswax Substances 0.000 claims description 39
- 239000008165 rice bran oil Substances 0.000 claims description 39
- 229930003427 Vitamin E Natural products 0.000 claims description 38
- 229940046009 Vitamin E Drugs 0.000 claims description 38
- 235000019165 vitamin E Nutrition 0.000 claims description 38
- 239000011709 vitamin E Substances 0.000 claims description 38
- 150000003712 vitamin E derivatives Chemical class 0.000 claims description 38
- 239000004408 titanium dioxide Substances 0.000 claims description 37
- 229940107702 Grapefruit seed extract Drugs 0.000 claims description 36
- 240000008529 Triticum aestivum Species 0.000 claims description 36
- 102000004169 proteins and genes Human genes 0.000 claims description 36
- 108090000623 proteins and genes Proteins 0.000 claims description 36
- 235000021307 wheat Nutrition 0.000 claims description 36
- 229940074047 Glyceryl Cocoate Drugs 0.000 claims description 35
- UIIMBOGNXHQVGW-UHFFFAOYSA-M NaHCO3 Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 34
- YJISHJVIRFPGGN-UHFFFAOYSA-N 5-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy-6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)O)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 YJISHJVIRFPGGN-UHFFFAOYSA-N 0.000 claims description 33
- 235000010804 Maranta arundinacea Nutrition 0.000 claims description 32
- 235000012419 Thalia geniculata Nutrition 0.000 claims description 31
- FODTZLFLDFKIQH-FSVGXZBPSA-N γ-Oryzanol Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 claims description 31
- 230000002335 preservative Effects 0.000 claims description 30
- 239000003755 preservative agent Substances 0.000 claims description 30
- 239000000126 substance Substances 0.000 claims description 30
- 235000009122 Rubus idaeus Nutrition 0.000 claims description 29
- 235000011034 Rubus glaucus Nutrition 0.000 claims description 28
- 238000007792 addition Methods 0.000 claims description 28
- 239000000758 substrate Substances 0.000 claims description 28
- 102000004190 Enzymes Human genes 0.000 claims description 26
- 108090000790 Enzymes Proteins 0.000 claims description 26
- 239000006185 dispersion Substances 0.000 claims description 26
- 229940088598 Enzyme Drugs 0.000 claims description 25
- 235000014360 Punica granatum Nutrition 0.000 claims description 25
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 24
- 229960001031 Glucose Drugs 0.000 claims description 24
- 239000008103 glucose Substances 0.000 claims description 24
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims description 23
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims description 23
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims description 23
- 239000000598 endocrine disruptor Substances 0.000 claims description 22
- 210000004080 Milk Anatomy 0.000 claims description 21
- 235000013336 milk Nutrition 0.000 claims description 21
- 239000008267 milk Substances 0.000 claims description 21
- 229940057428 LACTOPEROXIDASE Drugs 0.000 claims description 20
- 108010023244 Lactoperoxidase Proteins 0.000 claims description 20
- 102000028880 Lactoperoxidase Human genes 0.000 claims description 20
- 239000002537 cosmetic Substances 0.000 claims description 20
- 229940119170 jojoba wax Drugs 0.000 claims description 19
- 239000003963 antioxidant agent Substances 0.000 claims description 18
- 235000006708 antioxidants Nutrition 0.000 claims description 17
- 239000000839 emulsion Substances 0.000 claims description 17
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 17
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 17
- 231100000507 endocrine disrupting Toxicity 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 16
- 230000003078 antioxidant Effects 0.000 claims description 15
- 239000003205 fragrance Substances 0.000 claims description 15
- 239000010460 hemp oil Substances 0.000 claims description 15
- 235000010323 ascorbic acid Nutrition 0.000 claims description 14
- 239000011668 ascorbic acid Substances 0.000 claims description 14
- 239000002270 dispersing agent Substances 0.000 claims description 14
- 229960005070 ascorbic acid Drugs 0.000 claims description 13
- 235000021302 avocado oil Nutrition 0.000 claims description 13
- 239000008163 avocado oil Substances 0.000 claims description 13
- 235000015810 grayleaf red raspberry Nutrition 0.000 claims description 13
- 239000006210 lotion Substances 0.000 claims description 13
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims description 12
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims description 12
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims description 12
- 150000001747 carotenoids Chemical class 0.000 claims description 12
- 238000001816 cooling Methods 0.000 claims description 12
- 230000004224 protection Effects 0.000 claims description 12
- 235000019529 tetraterpenoid Nutrition 0.000 claims description 12
- 239000004863 Frankincense Substances 0.000 claims description 10
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2S,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 claims description 9
- 239000002199 base oil Substances 0.000 claims description 9
- 235000012239 silicon dioxide Nutrition 0.000 claims description 9
- 235000011236 Persea americana var americana Nutrition 0.000 claims description 8
- 240000006764 Punica granatum Species 0.000 claims description 8
- 235000019420 glucose oxidase Nutrition 0.000 claims description 8
- 244000144725 Amygdalus communis Species 0.000 claims description 7
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 7
- 108010015776 EC 1.1.3.4 Proteins 0.000 claims description 7
- 229940116332 GLUCOSE OXIDASE Drugs 0.000 claims description 7
- 239000004366 Glucose oxidase Substances 0.000 claims description 7
- 240000004546 Persea americana var. americana Species 0.000 claims description 7
- 235000019486 Sunflower oil Nutrition 0.000 claims description 7
- 239000007921 spray Substances 0.000 claims description 7
- 239000002600 sunflower oil Substances 0.000 claims description 7
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 6
- 240000007170 Cocos nucifera Species 0.000 claims description 6
- 240000007594 Oryza sativa Species 0.000 claims description 6
- 235000007164 Oryza sativa Nutrition 0.000 claims description 6
- 235000004443 Ricinus communis Nutrition 0.000 claims description 6
- 239000004359 castor oil Substances 0.000 claims description 6
- 235000019438 castor oil Nutrition 0.000 claims description 6
- UHZZMRAGKVHANO-UHFFFAOYSA-M 2-chloroethyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 claims description 5
- 240000006669 Helianthus annuus Species 0.000 claims description 5
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 5
- 240000003553 Leptospermum scoparium Species 0.000 claims description 5
- 240000008426 Persea americana Species 0.000 claims description 5
- 229940045898 SODIUM STEAROYL GLUTAMATE Drugs 0.000 claims description 5
- 239000000654 additive Substances 0.000 claims description 5
- 239000008168 almond oil Substances 0.000 claims description 5
- 239000008169 grapeseed oil Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 235000009566 rice Nutrition 0.000 claims description 5
- PNEYBMLMFCGWSK-UHFFFAOYSA-N AI2O3 Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 4
- 241000717739 Boswellia sacra Species 0.000 claims description 4
- 240000007436 Cananga odorata Species 0.000 claims description 4
- 229940113118 Carrageenan Drugs 0.000 claims description 4
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 4
- 240000005801 Carthamus tinctorius Species 0.000 claims description 4
- 240000000437 Eucalyptus leucoxylon Species 0.000 claims description 4
- 235000004694 Eucalyptus leucoxylon Nutrition 0.000 claims description 4
- 235000010705 Eucalyptus maculata Nutrition 0.000 claims description 4
- 235000009683 Eucalyptus polybractea Nutrition 0.000 claims description 4
- 235000009687 Eucalyptus sargentii Nutrition 0.000 claims description 4
- 235000018330 Macadamia integrifolia Nutrition 0.000 claims description 4
- 235000003800 Macadamia tetraphylla Nutrition 0.000 claims description 4
- 240000000912 Macadamia tetraphylla Species 0.000 claims description 4
- 235000014150 Myroxylon pereirae Nutrition 0.000 claims description 4
- 244000302151 Myroxylon pereirae Species 0.000 claims description 4
- 240000009023 Myrrhis odorata Species 0.000 claims description 4
- 235000007265 Myrrhis odorata Nutrition 0.000 claims description 4
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 4
- 240000003670 Sesamum indicum Species 0.000 claims description 4
- 235000004433 Simmondsia californica Nutrition 0.000 claims description 4
- CMPDPBDUZTUXAD-UHFFFAOYSA-N [3-hydroxy-2-(16-methylheptadecanoyloxy)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC(C)C CMPDPBDUZTUXAD-UHFFFAOYSA-N 0.000 claims description 4
- 235000020224 almond Nutrition 0.000 claims description 4
- 230000000111 anti-oxidant Effects 0.000 claims description 4
- 239000000679 carrageenan Substances 0.000 claims description 4
- 235000010418 carrageenan Nutrition 0.000 claims description 4
- 239000000969 carrier Substances 0.000 claims description 4
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 4
- 235000001612 eucalyptus Nutrition 0.000 claims description 4
- 235000001617 eucalyptus Nutrition 0.000 claims description 4
- 235000001621 eucalyptus Nutrition 0.000 claims description 4
- 235000006356 eucalyptus Nutrition 0.000 claims description 4
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 claims description 4
- 230000002766 immunoenhancement Effects 0.000 claims description 4
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 4
- 239000001157 myroxylon pereirae klotzsch resin Substances 0.000 claims description 4
- 235000005426 persea americana Nutrition 0.000 claims description 4
- 235000005227 red mallee Nutrition 0.000 claims description 4
- QKHBMQWPOUUMQZ-BDQAORGHSA-M sodium;hydron;(2S)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC([O-])=O QKHBMQWPOUUMQZ-BDQAORGHSA-M 0.000 claims description 4
- 239000011732 tocopherol Substances 0.000 claims description 4
- 229930003799 tocopherols Natural products 0.000 claims description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 4
- 235000019489 Almond oil Nutrition 0.000 claims description 3
- 241000209134 Arundinaria Species 0.000 claims description 3
- 235000009024 Ceanothus sanguineus Nutrition 0.000 claims description 3
- 241001672694 Citrus reticulata Species 0.000 claims description 3
- 240000000560 Citrus x paradisi Species 0.000 claims description 3
- 229940044949 Eucalyptus oil Drugs 0.000 claims description 3
- 235000010701 Lavanda vera Nutrition 0.000 claims description 3
- 240000002809 Lavandula angustifolia Species 0.000 claims description 3
- 235000003515 Lavandula officinalis Nutrition 0.000 claims description 3
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 3
- 241000378467 Melaleuca Species 0.000 claims description 3
- 235000011751 Pogostemon cablin Nutrition 0.000 claims description 3
- 240000002505 Pogostemon cablin Species 0.000 claims description 3
- 241000220317 Rosa Species 0.000 claims description 3
- 235000019485 Safflower oil Nutrition 0.000 claims description 3
- 235000007303 Thymus vulgaris Nutrition 0.000 claims description 3
- 240000002657 Thymus vulgaris Species 0.000 claims description 3
- 229960001295 Tocopherol Drugs 0.000 claims description 3
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 3
- 240000007329 Zingiber officinale Species 0.000 claims description 3
- 229940071160 cocoate Drugs 0.000 claims description 3
- 239000000470 constituent Substances 0.000 claims description 3
- 231100000049 endocrine disruptor Toxicity 0.000 claims description 3
- 239000010642 eucalyptus oil Substances 0.000 claims description 3
- 235000008397 ginger Nutrition 0.000 claims description 3
- 150000008131 glucosides Chemical class 0.000 claims description 3
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 3
- 229910000460 iron oxide Inorganic materials 0.000 claims description 3
- 239000001102 lavandula vera Substances 0.000 claims description 3
- 235000018219 lavender Nutrition 0.000 claims description 3
- 239000010466 nut oil Substances 0.000 claims description 3
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims description 3
- 235000005713 safflower oil Nutrition 0.000 claims description 3
- 239000003813 safflower oil Substances 0.000 claims description 3
- 239000008159 sesame oil Substances 0.000 claims description 3
- 235000011803 sesame oil Nutrition 0.000 claims description 3
- 238000004381 surface treatment Methods 0.000 claims description 3
- 239000001585 thymus vulgaris Substances 0.000 claims description 3
- 235000010384 tocopherol Nutrition 0.000 claims description 3
- FYGDTMLNYKFZSV-WFYNLLPOSA-N (2S,3R,4S,5S,6R)-2-[(2R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-WFYNLLPOSA-N 0.000 claims description 2
- 240000006054 Agastache cana Species 0.000 claims description 2
- 235000007639 Anthemis cotula Nutrition 0.000 claims description 2
- 229920002498 Beta-glucan Polymers 0.000 claims description 2
- DSSYKIVIOFKYAU-UHFFFAOYSA-N Camphor Chemical compound C1CC2(C)C(=O)CC1C2(C)C DSSYKIVIOFKYAU-UHFFFAOYSA-N 0.000 claims description 2
- 229960000846 Camphor Drugs 0.000 claims description 2
- 240000003538 Chamaemelum nobile Species 0.000 claims description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 2
- 241000723346 Cinnamomum camphora Species 0.000 claims description 2
- 235000005979 Citrus limon Nutrition 0.000 claims description 2
- 240000002268 Citrus limon Species 0.000 claims description 2
- 235000006965 Commiphora myrrha Nutrition 0.000 claims description 2
- 235000007129 Cuminum cyminum Nutrition 0.000 claims description 2
- 240000004559 Cuminum cyminum Species 0.000 claims description 2
- 235000017897 Cymbopogon citratus Nutrition 0.000 claims description 2
- 240000003312 Cymbopogon flexuosus Species 0.000 claims description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-α-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 2
- 240000001238 Gaultheria procumbens Species 0.000 claims description 2
- 235000007297 Gaultheria procumbens Nutrition 0.000 claims description 2
- 241000208152 Geranium Species 0.000 claims description 2
- 229940094952 Green Tea Extract Drugs 0.000 claims description 2
- 235000010650 Hyssopus officinalis Nutrition 0.000 claims description 2
- 235000010254 Jasminum officinale Nutrition 0.000 claims description 2
- 240000005385 Jasminum sambac Species 0.000 claims description 2
- 235000013628 Lantana involucrata Nutrition 0.000 claims description 2
- 240000005183 Lantana involucrata Species 0.000 claims description 2
- 235000016887 Leptospermum scoparium Nutrition 0.000 claims description 2
- 235000019493 Macadamia oil Nutrition 0.000 claims description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N Manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 claims description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 2
- 235000014749 Mentha crispa Nutrition 0.000 claims description 2
- 240000006217 Mentha pulegium Species 0.000 claims description 2
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 2
- 240000000744 Mentha spicata Species 0.000 claims description 2
- 240000009136 Monarda didyma Species 0.000 claims description 2
- 235000010672 Monarda didyma Nutrition 0.000 claims description 2
- 235000010676 Ocimum basilicum Nutrition 0.000 claims description 2
- 240000003982 Ocimum basilicum Species 0.000 claims description 2
- 235000006297 Origanum majorana Nutrition 0.000 claims description 2
- 240000000783 Origanum majorana Species 0.000 claims description 2
- 235000006990 Pimenta dioica Nutrition 0.000 claims description 2
- 240000008474 Pimenta dioica Species 0.000 claims description 2
- 235000012550 Pimpinella anisum Nutrition 0.000 claims description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 2
- 241000018646 Pinus brutia Species 0.000 claims description 2
- 235000011613 Pinus brutia Nutrition 0.000 claims description 2
- 235000009984 Pterocarpus indicus Nutrition 0.000 claims description 2
- 240000008251 Pterocarpus indicus Species 0.000 claims description 2
- 235000002912 Salvia officinalis Nutrition 0.000 claims description 2
- 240000007164 Salvia officinalis Species 0.000 claims description 2
- 235000002911 Salvia sclarea Nutrition 0.000 claims description 2
- 240000003489 Salvia sclarea Species 0.000 claims description 2
- 240000000513 Santalum album Species 0.000 claims description 2
- 235000008632 Santalum album Nutrition 0.000 claims description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims description 2
- 240000005147 Syzygium aromaticum Species 0.000 claims description 2
- 229960001452 alpha-Tocopherol Acetate Drugs 0.000 claims description 2
- 229930007890 camphor Natural products 0.000 claims description 2
- 235000001544 chamomile Nutrition 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 239000005350 fused silica glass Substances 0.000 claims description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims description 2
- 235000020688 green tea extract Nutrition 0.000 claims description 2
- 239000010468 hazelnut oil Substances 0.000 claims description 2
- 235000001050 hortel pimenta Nutrition 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 235000006677 lemon beebalm Nutrition 0.000 claims description 2
- 239000010469 macadamia oil Substances 0.000 claims description 2
- 239000000395 magnesium oxide Substances 0.000 claims description 2
- 229910000468 manganese oxide Inorganic materials 0.000 claims description 2
- AMWRITDGCCNYAT-UHFFFAOYSA-L manganese(II,III) oxide Inorganic materials [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 claims description 2
- 235000004383 oregano Nutrition 0.000 claims description 2
- 235000018838 origanum vulgare Nutrition 0.000 claims description 2
- 235000007735 peppermint Nutrition 0.000 claims description 2
- 235000006678 peppermint Nutrition 0.000 claims description 2
- 235000015132 peppermint Nutrition 0.000 claims description 2
- 235000002020 sage Nutrition 0.000 claims description 2
- 238000003892 spreading Methods 0.000 claims description 2
- 210000000434 stratum corneum Anatomy 0.000 claims description 2
- 229960001231 Choline Drugs 0.000 claims 2
- 229940067631 Phospholipids Drugs 0.000 claims 2
- 240000006809 Thalia geniculata Species 0.000 claims 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Vitamin C Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- CRBHXDCYXIISFC-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CC[O-] CRBHXDCYXIISFC-UHFFFAOYSA-N 0.000 claims 2
- 235000019441 ethanol Nutrition 0.000 claims 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims 2
- 235000019477 peppermint oil Nutrition 0.000 claims 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims 1
- 240000007087 Apium graveolens Species 0.000 claims 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims 1
- 235000010591 Appio Nutrition 0.000 claims 1
- 241000218645 Cedrus Species 0.000 claims 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims 1
- 240000004499 Cinnamomum aromaticum Species 0.000 claims 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims 1
- 235000004310 Cinnamomum zeylanicum Nutrition 0.000 claims 1
- 240000003624 Cymbopogon nardus Species 0.000 claims 1
- 235000018791 Cymbopogon nardus Nutrition 0.000 claims 1
- 210000002969 Egg Yolk Anatomy 0.000 claims 1
- 229940089020 Evening primrose oil Drugs 0.000 claims 1
- 235000010469 Glycine max Nutrition 0.000 claims 1
- 240000007842 Glycine max Species 0.000 claims 1
- 229940087603 Grape Seed Extract Drugs 0.000 claims 1
- 235000019487 Hazelnut oil Nutrition 0.000 claims 1
- 241000592238 Juniperus communis Species 0.000 claims 1
- 229940067606 Lecithin Drugs 0.000 claims 1
- 235000019501 Lemon oil Nutrition 0.000 claims 1
- 235000019483 Peanut oil Nutrition 0.000 claims 1
- 240000003136 Rosmarinus officinalis Species 0.000 claims 1
- 244000044822 Simmondsia californica Species 0.000 claims 1
- 229940042585 Tocopherol Acetate Drugs 0.000 claims 1
- 235000019498 Walnut oil Nutrition 0.000 claims 1
- 239000010619 basil oil Substances 0.000 claims 1
- 229940018006 basil oil Drugs 0.000 claims 1
- 235000019480 chamomile oil Nutrition 0.000 claims 1
- 239000010628 chamomile oil Substances 0.000 claims 1
- 235000017803 cinnamon Nutrition 0.000 claims 1
- 239000001071 citrus reticulata blanco var. mandarin Substances 0.000 claims 1
- 229940038226 comfrey root extract Drugs 0.000 claims 1
- 235000013345 egg yolk Nutrition 0.000 claims 1
- 235000008524 evening primrose extract Nutrition 0.000 claims 1
- 239000010475 evening primrose oil Substances 0.000 claims 1
- 239000010649 ginger oil Substances 0.000 claims 1
- 235000002532 grape seed extract Nutrition 0.000 claims 1
- 239000008079 hexane Substances 0.000 claims 1
- 239000001735 hyssopus officinalis l. herb oil Substances 0.000 claims 1
- 239000000787 lecithin Substances 0.000 claims 1
- 235000010445 lecithin Nutrition 0.000 claims 1
- 239000010501 lemon oil Substances 0.000 claims 1
- 239000001627 myristica fragrans houtt. fruit oil Substances 0.000 claims 1
- 235000008390 olive oil Nutrition 0.000 claims 1
- 239000004006 olive oil Substances 0.000 claims 1
- 239000000312 peanut oil Substances 0.000 claims 1
- 235000019719 rose oil Nutrition 0.000 claims 1
- 239000010666 rose oil Substances 0.000 claims 1
- 229940092258 rosemary extract Drugs 0.000 claims 1
- 235000020748 rosemary extract Nutrition 0.000 claims 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 claims 1
- 239000010671 sandalwood oil Substances 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
- 239000001717 vitis vinifera seed extract Substances 0.000 claims 1
- 239000008170 walnut oil Substances 0.000 claims 1
- 230000000475 sunscreen Effects 0.000 description 52
- 239000004615 ingredient Substances 0.000 description 44
- 229940092738 beeswax Drugs 0.000 description 34
- 235000018102 proteins Nutrition 0.000 description 34
- 240000005504 Maranta arundinacea Species 0.000 description 32
- 238000009472 formulation Methods 0.000 description 26
- 230000000694 effects Effects 0.000 description 20
- 241000219991 Lythraceae Species 0.000 description 17
- 230000002708 enhancing Effects 0.000 description 16
- 230000004044 response Effects 0.000 description 13
- 239000011780 sodium chloride Substances 0.000 description 13
- 235000019154 vitamin C Nutrition 0.000 description 13
- 239000011718 vitamin C Substances 0.000 description 13
- TYQCGQRIZGCHNB-JLAZNSOCSA-N L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 12
- 229930003268 Vitamin C Natural products 0.000 description 12
- 239000000284 extract Substances 0.000 description 11
- 230000002633 protecting Effects 0.000 description 11
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 10
- 230000002124 endocrine Effects 0.000 description 10
- 150000003839 salts Chemical class 0.000 description 10
- 206010042496 Sunburn Diseases 0.000 description 9
- 210000004027 cells Anatomy 0.000 description 9
- 238000004140 cleaning Methods 0.000 description 9
- 241001529742 Rosmarinus Species 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 230000001681 protective Effects 0.000 description 8
- 238000011012 sanitization Methods 0.000 description 8
- 229910001220 stainless steel Inorganic materials 0.000 description 8
- 239000010935 stainless steel Substances 0.000 description 8
- 206010015150 Erythema Diseases 0.000 description 7
- 241000124008 Mammalia Species 0.000 description 7
- 230000000845 anti-microbial Effects 0.000 description 7
- 235000020127 ayran Nutrition 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 7
- 239000011701 zinc Substances 0.000 description 7
- 229910052725 zinc Inorganic materials 0.000 description 7
- 235000003717 Boswellia sacra Nutrition 0.000 description 6
- 235000012035 Boswellia serrata Nutrition 0.000 description 6
- 240000007551 Boswellia serrata Species 0.000 description 6
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 6
- 231100000321 erythema Toxicity 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- 235000019388 lanolin Nutrition 0.000 description 6
- 230000002232 neuromuscular Effects 0.000 description 6
- 229920001542 oligosaccharide Polymers 0.000 description 6
- 150000002482 oligosaccharides Polymers 0.000 description 6
- 230000001603 reducing Effects 0.000 description 6
- 230000002588 toxic Effects 0.000 description 6
- 231100000331 toxic Toxicity 0.000 description 6
- 235000013311 vegetables Nutrition 0.000 description 6
- 210000004907 Glands Anatomy 0.000 description 5
- 239000004166 Lanolin Substances 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 210000000056 organs Anatomy 0.000 description 5
- 229960003471 retinol Drugs 0.000 description 5
- 235000010339 sodium tetraborate Nutrition 0.000 description 5
- 238000010998 test method Methods 0.000 description 5
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 229930003231 vitamins Natural products 0.000 description 5
- 229920000189 Arabinogalactan Polymers 0.000 description 4
- 229940039717 Lanolin Drugs 0.000 description 4
- 240000003183 Manihot esculenta Species 0.000 description 4
- 210000004927 Skin cells Anatomy 0.000 description 4
- 229940029983 VITAMINS Drugs 0.000 description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 4
- 229940045997 Vitamin A Drugs 0.000 description 4
- 229940021016 Vitamin IV solution additives Drugs 0.000 description 4
- 210000002268 Wool Anatomy 0.000 description 4
- 125000000129 anionic group Chemical group 0.000 description 4
- 239000004599 antimicrobial Substances 0.000 description 4
- 230000022534 cell killing Effects 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 239000010954 inorganic particle Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000001186 myroxylon pereirae klotzsch oil Substances 0.000 description 4
- 239000005445 natural product Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000004043 responsiveness Effects 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 230000037072 sun protection Effects 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- 229940069521 Aloe Extract Drugs 0.000 description 3
- 229960002852 Ellagic Acid Drugs 0.000 description 3
- 229920002079 Ellagic acid Polymers 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 210000000987 Immune System Anatomy 0.000 description 3
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 241000221095 Simmondsia Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 3
- 230000003110 anti-inflammatory Effects 0.000 description 3
- 238000004166 bioassay Methods 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000000254 damaging Effects 0.000 description 3
- 235000004132 ellagic acid Nutrition 0.000 description 3
- 239000000077 insect repellent Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229930014626 natural products Natural products 0.000 description 3
- 235000014571 nuts Nutrition 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 210000001519 tissues Anatomy 0.000 description 3
- 230000036572 transepidermal water loss Effects 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- 238000009736 wetting Methods 0.000 description 3
- 230000002087 whitening Effects 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical group CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 2
- 229940024606 Amino Acids Drugs 0.000 description 2
- 229940019746 Antifibrinolytic amino acids Drugs 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 208000005679 Eczema Diseases 0.000 description 2
- 229940021015 I.V. solution additive Amino Acids Drugs 0.000 description 2
- OAIJSZIZWZSQBC-LWRKPGOESA-N Lycopene Natural products CC(C)=CCC\C(C)=C/C=C/C(/C)=C\C=C\C(\C)=C/C=C/C=C(/C)\C=C\C=C(\C)/C=C/C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-LWRKPGOESA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 210000003205 Muscles Anatomy 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 229940068065 Phytosterols Drugs 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003712 anti-aging Effects 0.000 description 2
- 239000003429 antifungal agent Substances 0.000 description 2
- 230000000903 blocking Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 201000009030 carcinoma Diseases 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 230000001684 chronic Effects 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 230000035614 depigmentation Effects 0.000 description 2
- 201000004624 dermatitis Diseases 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 231100001003 eczema Toxicity 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 230000001815 facial Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 235000012055 fruits and vegetables Nutrition 0.000 description 2
- 150000004676 glycans Polymers 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 230000000899 immune system response Effects 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 239000007934 lip balm Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 230000003287 optical Effects 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Polymers 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 201000004681 psoriasis Diseases 0.000 description 2
- 239000000718 radiation-protective agent Substances 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 230000001235 sensitizing Effects 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000005480 straight-chain fatty acid group Chemical class 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000036561 sun exposure Effects 0.000 description 2
- 230000000699 topical Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 150000003700 vitamin C derivatives Chemical class 0.000 description 2
- 235000020795 whole food diet Nutrition 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N (1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(1R,4R)-4-hydroxy-2,6,6-trimethylcyclohex-2-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethylcyclohex-3-en-1-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-QAYBQHTQSA-N (1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(4R)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-QAYBQHTQSA-N 0.000 description 1
- ZCDMRPMKAQLWAO-PZLFCYFRSA-N (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid;(9Z,12Z)-octadeca-9,12-dienoic acid Chemical class CCCCC\C=C/C\C=C/CCCCCCCC(O)=O.CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O ZCDMRPMKAQLWAO-PZLFCYFRSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-M 16-methylheptadecanoate Chemical class CC(C)CCCCCCCCCCCCCCC([O-])=O XDOFQFKRPWOURC-UHFFFAOYSA-M 0.000 description 1
- BVDRUCCQKHGCRX-UHFFFAOYSA-N 2,3-dihydroxypropyl formate Chemical compound OCC(O)COC=O BVDRUCCQKHGCRX-UHFFFAOYSA-N 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N 3-(2,3-dihydroxypropoxy)propane-1,2-diol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 description 1
- 208000009621 Actinic Keratosis Diseases 0.000 description 1
- 235000006667 Aleurites moluccana Nutrition 0.000 description 1
- 244000136475 Aleurites moluccana Species 0.000 description 1
- 229940061720 Alpha Hydroxy Acids Drugs 0.000 description 1
- 241000256837 Apidae Species 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 240000005781 Arachis hypogaea Species 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 229940072107 Ascorbate Drugs 0.000 description 1
- 229940083828 Bioflavonoid drugs for capillary stabilizing Drugs 0.000 description 1
- 229940093797 Bioflavonoids Drugs 0.000 description 1
- 208000002352 Blister Diseases 0.000 description 1
- 210000004369 Blood Anatomy 0.000 description 1
- 235000007689 Borago officinalis Nutrition 0.000 description 1
- 240000004355 Borago officinalis Species 0.000 description 1
- OVTZSFFUIFYMRD-UHFFFAOYSA-N CCOC(OCC)(OCC)CCCCCCC([SiH3])=O Chemical compound CCOC(OCC)(OCC)CCCCCCC([SiH3])=O OVTZSFFUIFYMRD-UHFFFAOYSA-N 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 241000218236 Cannabis Species 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 244000068645 Carya illinoensis Species 0.000 description 1
- 235000009025 Carya illinoensis Nutrition 0.000 description 1
- 239000010369 Cascara Substances 0.000 description 1
- 229940107161 Cholesterol Drugs 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 240000003472 Citrus aurantium Species 0.000 description 1
- 235000001759 Citrus maxima Nutrition 0.000 description 1
- 240000003641 Citrus maxima Species 0.000 description 1
- 235000000228 Citrus myrtifolia Nutrition 0.000 description 1
- 235000016646 Citrus taiwanica Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 240000009226 Corylus americana Species 0.000 description 1
- 235000001543 Corylus americana Nutrition 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 240000006652 Cupressus sempervirens Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 1
- 240000002860 Daucus carota Species 0.000 description 1
- 235000002243 Daucus carota subsp sativus Nutrition 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 206010012444 Dermatitis diaper Diseases 0.000 description 1
- 208000003105 Diaper Rash Diseases 0.000 description 1
- 102000016680 Dioxygenases Human genes 0.000 description 1
- 108010028143 Dioxygenases Proteins 0.000 description 1
- 230000036826 Excretion Effects 0.000 description 1
- 206010073306 Exposure to radiation Diseases 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N Ferulic acid Chemical class COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 241001528248 Frangula Species 0.000 description 1
- 241000556215 Frangula purshiana Species 0.000 description 1
- 229940082009 GALACTOARABINAN Drugs 0.000 description 1
- 229940087559 GRAPE SEED Drugs 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 210000004209 Hair Anatomy 0.000 description 1
- 241000035850 Helichrysum petiolare Species 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N Hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- 210000001624 Hip Anatomy 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022114 Injury Diseases 0.000 description 1
- 235000002562 Irvingia gabonensis Nutrition 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- XMAYWYJOQHXEEK-OZXSUGGESA-N Ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 240000001422 Laurus nobilis Species 0.000 description 1
- 229940010454 Licorice Drugs 0.000 description 1
- 210000004185 Liver Anatomy 0.000 description 1
- 229960005375 Lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-NRHWGSPPSA-N Lutein Natural products O[C@H]1C=C(C)[C@H](/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=2C(C)(C)C[C@H](O)CC=2C)\C)/C)\C)/C)C(C)(C)C1 KBPHJBAIARWVSC-NRHWGSPPSA-N 0.000 description 1
- 229940078752 MAGNESIUM ASCORBYL PHOSPHATE Drugs 0.000 description 1
- 206010025650 Malignant melanoma Diseases 0.000 description 1
- 235000004456 Manihot esculenta Nutrition 0.000 description 1
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 240000004119 Melissa officinalis Species 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- 240000006984 Myristica fragrans Species 0.000 description 1
- VODZWWMEJITOND-OWWNRXNESA-N N-Stearoylsphingosine Chemical compound CCCCCCCCCCCCCCCCCC(=O)NC(CO)C(O)\C=C\CCCCCCCCCCCCC VODZWWMEJITOND-OWWNRXNESA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 235000004496 Oenothera biennis Nutrition 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 229940012843 Omega-3 Fatty Acids Drugs 0.000 description 1
- 229940033080 Omega-6 Fatty Acids Drugs 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- ZIWPYEIAPMTNTE-WRABICDASA-N Oryzanol Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@@]4(C)[C@@H]5CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC(=C)C(C)C)(C)C)=C1 ZIWPYEIAPMTNTE-WRABICDASA-N 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N Phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 229960005323 Phenoxyethanol Drugs 0.000 description 1
- 229960005190 Phenylalanine Drugs 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 240000000129 Piper nigrum Species 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 231100000614 Poison Toxicity 0.000 description 1
- 229920001451 Polypropylene glycol Polymers 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 240000005204 Prunus armeniaca Species 0.000 description 1
- 206010037844 Rash Diseases 0.000 description 1
- 235000003942 Rubus occidentalis Nutrition 0.000 description 1
- 240000002345 Rubus occidentalis Species 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N Sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 240000000429 Spondias pinnata Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229960004793 Sucrose Drugs 0.000 description 1
- 231100000765 Toxin Toxicity 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 239000004904 UV filter Substances 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 235000007769 Vetiveria zizanioides Nutrition 0.000 description 1
- 244000284012 Vetiveria zizanioides Species 0.000 description 1
- 229940088594 Vitamin Drugs 0.000 description 1
- 229930003629 Vitamin B6 Natural products 0.000 description 1
- 229940011671 Vitamin B6 Drugs 0.000 description 1
- JKQXZKUSFCKOGQ-PQJNXSRMSA-N Zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C/C=C/C(/C)=C\C=C\C=C(\C)/C=C/C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-PQJNXSRMSA-N 0.000 description 1
- 238000005296 abrasive Methods 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000000274 adsorptive Effects 0.000 description 1
- 231100000494 adverse effect Toxicity 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000843 anti-fungal Effects 0.000 description 1
- 238000000222 aromatherapy Methods 0.000 description 1
- 230000003190 augmentative Effects 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000013614 black pepper Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atoms Chemical group C* 0.000 description 1
- 229940058505 cascara Drugs 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 239000007957 coemulsifier Substances 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 230000001472 cytotoxic Effects 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000002354 daily Effects 0.000 description 1
- 230000002939 deleterious Effects 0.000 description 1
- 230000001419 dependent Effects 0.000 description 1
- 230000000994 depressed Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- KARVSHNNUWMXFO-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane;hydrate Chemical compound O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Al]O[Al]=O KARVSHNNUWMXFO-UHFFFAOYSA-N 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 229910021485 fumed silica Inorganic materials 0.000 description 1
- QUEDXNHFTDJVIY-WENCSYSZSA-N gamma-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@](CCC[C@@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-WENCSYSZSA-N 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002068 genetic Effects 0.000 description 1
- 108010046301 glucose peroxidase Proteins 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000006486 human diet Nutrition 0.000 description 1
- 230000000887 hydrating Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- AAUNBWYUJICUKP-UHFFFAOYSA-N hypoiodite Chemical compound I[O-] AAUNBWYUJICUKP-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000002452 interceptive Effects 0.000 description 1
- 239000012182 japan wax Substances 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 230000002147 killing Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 230000002045 lasting Effects 0.000 description 1
- 235000014063 licorice root Nutrition 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000000813 microbial Effects 0.000 description 1
- 230000003278 mimic Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 230000003020 moisturizing Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000001702 nutmeg Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 239000011146 organic particle Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- ZCZCOXLLICTZAH-UHFFFAOYSA-M oxido thiocyanate Chemical compound [O-]SC#N ZCZCOXLLICTZAH-UHFFFAOYSA-M 0.000 description 1
- SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Chemical class [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000036961 partial Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000243 photosynthetic Effects 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001888 polyacrylic acid Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 238000007780 powder milling Methods 0.000 description 1
- 239000011164 primary particle Substances 0.000 description 1
- 230000002035 prolonged Effects 0.000 description 1
- 229910052904 quartz Inorganic materials 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reduced Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 125000000946 retinyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C1=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 230000002000 scavenging Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000000087 stabilizing Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-M stearate Chemical compound CCCCCCCCCCCCCCCCCC([O-])=O QIQXTHQIDYTFRH-UHFFFAOYSA-M 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 230000001502 supplementation Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000002522 swelling Effects 0.000 description 1
- 230000002195 synergetic Effects 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 229910001929 titanium oxide Inorganic materials 0.000 description 1
- 125000002640 tocopherol group Chemical group 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 108020003112 toxins Proteins 0.000 description 1
- 230000001131 transforming Effects 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 150000003697 vitamin B6 derivatives Chemical class 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000002747 voluntary Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 238000004078 waterproofing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 235000005765 wild carrot Nutrition 0.000 description 1
- 230000000800 xenoestrogenic Effects 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 150000003772 α-tocopherols Chemical class 0.000 description 1
- 150000003785 γ-tocopherols Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
- A61K8/9767—Pinaceae [Pine family], e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/26—Optical properties
- A61K2800/262—Transparent; Translucent
Abstract
A composition comprising purified water using ozonation, ionization, or distillation or any combination thereof wherein alcohol may be substituted for, or combined with water at least one emollient including but not limited to chitosan, and aloe vera gel, individually or in any combination; an oil component with spf boosting agents including but not limited to; ethyl macadamiate, non-toxic silicone oil and essential oils, butter milk, waxes impregnated with inorganic sun-block or sunscreen agent and organic/inorganic micronized particles, wood powder and bentonite clay, keratin, either individually or in any combination; at least one inorganic sun-block or sunscreen agent including any metal oxide, glass microsphere, silica and silica compound, and optionally metal oxide pigments with particles that are micronized, submicronized, nanoparticle sized, or otherwise individually or in any combination that can be homogenized in either a water phase, a water-aloe phase, an oil phase or any phase of said composition; at least one emulsifier wherein said emulsifier includes but is not limited to a phospholipid and/or liposome or an aloe vera gel or an ester of coconut oil individually or in any combination, for emulsifying the water, water-aloe, or oil phase in combination with an homogenizer; where any of components are preferably mixed with an homogenizer and where an appropriate thickening agent including but not limited to xanthan gum, carageenan, either individually or in any combination is added as required.
Description
Disclosure
TITLE OF DISCLOSURE
HIGH SPF TRANSPARENT OR TRANSLUCENT, CYTOPROTECTIVE,
BIODEGRADABLE, UV RADIATION RESISTANT COMPOSITIONS
PRIORITY
We (I) hereby claim the benefit of this disclosure under Title 35, United States Code 119(e) of the United States of provisional application 60/918,731, filed 19 March 2007, entitled "SPF Compositions With Natural SPF Boosters" and from provisional application 60/905,453, filed 07 March 2007, entitled "SPF Compositions". In addition we claim benefit Title 35, United States Code 120 from U.S. Patent 6,866,841 filed August 9, 2001 and granted March 15, 2005.
FIELD OF DISCLOSURE
This invention relates to new and useful ultraviolet radiation protective agents that can be used as beneficial sunscreens and sun-blocks in various compositions or formulations, • specifically those of a high SPF value (15-30, or greater). The compositions contain only ingredients derived directly from naturally earth-occurring substances and offer enhanced protection. A specific test methodology (biological based) is available to determine not only if the substances and resulting composition possess endocrine disrupters, but also determines the relative strength or concentration of the endocrine disrupter in a specific formulation.
BACKGROUND OF THE DISCLOSURE Although a tan has long been considered a symbol indicative of good health and the ability to secure sufficient leisure time to enjoy many and numerous outdoor activities, it has become very evident that excessive exposure of the human skin to sunlight is harmful.
It is well documented that human skin, and most mammalian skin, is sensitive to sunlight and artificial light containing radiation of wavelengths between about 290 nanometers (run) and 400 nm. Ultraviolet radiation of wavelengths between about 290 nm and 320 ran (UV-B region) has been known to rapidly produce damaging effects on the skin including reddening or erythema, edema, blistering or other skin eruptions in more severe cases. Prolonged or chronic exposure to radiation in this wavelength range has been associated with serious skin conditions such as actinic keratoses and carcinomas. In recent years, concern has also been
expressed regarding ultraviolet radiation of wavelengths above 320 nm (UV-A region) and the adverse effects of such radiation on human skin. The radiation between 320 and 400 nm also contributes to the premature aging of the skin. In addition, recent studies indicate that chronic sun exposure limits the immuno-response of the skin. There is some evidence that a tan will offer some protection against burning but that the tan is quite ineffectual against many other types of solar damage and there is no evidence that a tan increases immuno- responsive function in human skin.
Growing public awareness that the enjoyment of outdoor activities includes the need for adequate sun protection has led to an unprecedented growth in the area of sunscreen products. A study by Margaret Schlumpf from the Institute of Pharmacology and Toxicology at the University of Zurich, supports earlier health concerns regarding the use of endocrine disrupting organic substances in nearly all UV screening chemicals used in sunscreens. Additionally, the use of aloe, or more specifically aloe barbadensis Miller has heretofore been known to be a useful agent for the formulation of sunscreens as well as a substance that can both reduce UV damage to human skin that is inflamed and also promote healing. What was not well documented until recent publications and a subsequent U.S. patent 5,824,659 by Strickland and coworkers is that mono and polysaccharide extracts found in all Aloe plants, normally removed during carbon adsorptive processing, is capable of providing cytoprotection to the mammalian skin. This extract boosts the immune system response of the skin, thereby significantly reducing the risk to various forms of skin cancer. There is strong evidence to suggest that this beneficial effect translates to skin in most mammals, thereby the present invention provides a possible preventative formulation for animals in zoos or other habitats where UV exposure could also be hazardous to the animals' health.
It is therefore desirable to provide a UV protective product that has the following attributes: protection in the UV-A and UV-B long range and short range ultraviolet radiation ranges; maintenance of coverage, i.e., waterproof or at least water resistant and perspiration proof; application and use convenience, i.e., ease of application, invisibility, non-staining and non- greasy; and freedom from irritation as a result of its ingredients, in particular, its active sunblock or sunscreen ingredients should also be void of any known or suspected endocrine disrupters. Recent interest in this area includes some concerns over the irritancy and sensitization problems in addition to the endocrine disruptive nature that may occur in some individuals utilizing sunscreen products with high SPF values containing organic sunscreen
agents. In addition, the UV protective product could also include known cytoprotective oligosaccharides from aloe barbadensis Miller preventing damage to the skin immune system caused by harmful UV radiation. "Cold-pressed" Aloe which contains the beneficial oligosaccharides and provides an emollient base for the UV protective formulation is possibly the best known choice as a cytoprotective agent that inhibits the loss of skin immuno- competency induced by ultraviolet radiation, as this agent is readily available and comparably inexpensive. Other such inhibitors are not yet well known but it is believed that amino-acids, vitamins or pro-vitamins, carotenoids, nucleo- derivatives, and vegetable extracts, wherein said aminoacids comprise tryptophan, histidine, phenylalanine, tyrosine, said vitamins and provitamins comprise vitamin B6, vitamin A, vitamin E, tocopherols, beta carotene, bioflavonoids, nucleotides and polymers thereof, cascara, frangula, camomile, hyperic, calendula, elicriso, licorice or essential oils thereof all may have similar cytoprotective or immune boosting effects on mammalian skin. The essential oils of frankincense and rosemary have been found to work effectively and synergistically in strengthening the neuromuscular response of patients who are exposed to its scent in combination with compositions of the present invention.
One current measure of effectiveness of a sun protective product is indicated by its sun protection factor (SPF). The sun protection factor is the ratio of the amount of exposure (dose) required to produce a minimal erythema reaction in protected skin to the amount required to produce the same reaction in unprotected skin. The absolute dose differs for each human and for each mammal, and is largely dependent on genetic predisposition and ethnic origin of the human. If a human or other mammal would normally require ten minute exposure to sunlight to develop a minimal erythema reaction, then using an SPF 15 sun-block should allow for tolerance of up to 150 minutes of sunlight before developing a minimal erythema. Relatively recent public awareness of the problems of exposure to sunlight has led to a demand for sun-block products with high SPF values, i.e., at or above SPF 8.
What has not been well considered in the sun protection and cosmetics industry heretofore, is the possibility of enhancing the immuno- responsiveness of skin cells to UV light by the proper topical application such as described above by the use of extracts of aloe or similar naturally occurring substances (including kukua nut extract for example or other similar antiinflammatory naturally occurring substances such as carotenoids and melaleuca oils). Such substances would preferably not be processed, but if the beneficial effects are not lost during
processing, then either the processed or non-processed substance may be used. The importance of processing within a short time period after harvesting the aloe plant or other plants/nuts, etc. as well as keeping the plant and subsequent plant extract cool (at or below room temperature) during processing is now well understood. Essential oils including specifically frankincense and rosemary have been shown to possibly have immuno-enhancing properties, as determined by Kinesiologist Dr. John Schmidt of Triangle Wellness Center at 182 Wind Chime Ct. Ste. 203 Raleigh, North Carolina 27615. This was determined by a strengthening in neuromuscular response using scent (aroma) testing of these essential oils. The testing was performed both together with compositions of the present invention and alone.
Most recently (within the year 2007 and early 2008), Burt's Bees (now owned by Chlorox) and Whole Foods Market have started to introduce the concept of "acceptable" ingredients for cosmetics and other "skinceuticals" including SPF products. Whole Foods Market's Premium Body Care line, in fact, has produced a March 2008 brochure identifying more than 250 unacceptable ingredients for "premium body care". These include parabens, polypropylene, and polyethylene glycols, sodium laureth sulfates, and specific preservatives, fragrances, and surfactants (as well as emulsifiers). The present invention provides SPF products which meet these new stringent requirements, currently regarded as the most difficult to achieve within the industry.
There is some evidence that a tan will offer some protection against burning but that the tan is quite ineffectual against many other types of solar damage and there is no evidence that a tan increases immuno-responsive function in human skin.
With overexposure to UV light, the human immune system becomes depressed. Most sunscreens further compromise the immune system by including ingredients which lead to the creation of additional free radicals - organic sunscreens that decompose in the presence of UV light. The formulations of the present disclosure, by contrast, contain ingredients which absorb or quench free radicals so that they can not further damage the cells of the skin. The compositions contains ingredients known to boost carotenoid levels, including cold-pressed aloe vera gel and beta glucan, as well as Vitamins C & E, which bind with carotenoids to further boost anti-oxidant levels in the skin.
More than 600 carotenoids have been identified in nature but less than 50 are abundant in the human diet. Among these, five carotenoids, b-carotene, a-carotene, lycopene, lutein, and zeaxanthin are found in the blood and known to be important in human health A large number of epidemiological and experimental studies offer strong evidence that carotenoids are nutritionally important for normal cell regeneration, plus numerous other health aspects linked to unstable oxygen molecules called free radicals. Most of the health benefits of carotenoids are associated with their action as antioxidants, that is, they protect cells and tissues from the effects of free radicals. Carotenoids are not soluble in water and thus would be added to the water/aloe phase of the present compositions within this disclosure.
Biophotonic scanning methodology (currently marketed by Pharmanex) allows for current and future development of formulations that are the most comprehensive, scientifically accepted and proven means for providing immuno-enhancing protection from free radical generation due to UV radiation from the sun. Using proper wavelengths emitted by laser or LED or other light sources, additional (other than carotenoid) anti-oxidant wavelength specific compound concentrations can also be measured. This transformation, from qualitative to quantitative measurement of the anti-oxidant levels in any individual's skin, makes it possible to determine the effectiveness of any current or future formulation specifically designed to guard from overexposure to the sun's harmful radiation. Free radicals are scavenged by anti-oxidants which equates to lower exposure to cytotoxic compounds and the ability to maintain healthy skin cells and tissue without suppression of the immune function associated with the same skin cells and tissue. This technique, including measurement and design of new and better sunscreen and sunblock formulations is also a part of the present disclosure. SUMMARY OF THE DISCLOSURE This invention relates to new and useful ultraviolet radiation protective agents in combination with lotions, cremes, pastes, sprays, Hp balms, etc. that can be used as beneficial sun-blocks and in a specific instance as sunscreens in various compositions or formulations and which contain only ingredients derived directly from naturally earth-occurring substances, where direct derivation is defined as one or two steps removed from naturally earth-occurring ingredients or by a recent disclosure by Whole Food Market premium body care line.
An example of an ingredient that is not directly derived from naturally earth-occurring substances is silicone oil, which is derived from synthetic ingredients. The compositions
include enhanced protection by providing cytoprotective additives (derived from a single pure aloe source) for mammalian skin while also providing avoidance from endocrine disrupting agents. It has been determined at least as early as July 2001, that sunscreen agents used in almost all currently marketed and sold ultraviolet protective compositions are essentially void of any cytoprotective agents and contain suspected or documented endocrine disruptive additives in both the active and non-active ingredients. To ensure that there are no endocrine disrupters in the product, the invention adopts a relevant bioassay (or test method), which can both detect these chemicals (endocrine disrupters), as well as provide a relevant estimate of their endocrine disrupting potency.
It is desirable in the present invention to provide improved sunscreen and sun-block agents and compositions. Review of the literature, and currently marketed compositions reveal that there exists an unnecessary potential risk to human health (or other mammals) with the current commercially available formulations on the world- wide market.
It is desirable in the present invention to provide sunscreen compositions containing sunscreen agents that overcome the disadvantages of heretofore available compositions and to provide non-endocrine disruptive, adequate, safe protection for mammalian skin. The use of cartotenoids and a biophotonic scanner to optimize (for cost and effectiveness) anti- oxidant concentrations within these unique compositions is also a part of this disclosure.
Another desirable portion of this invention addresses the potential risks and disadvantages, provides a viable and economically attractive alternative to the present commercial market, and proposes a new and safer rating system to rank these products for the consumer.
Another desired feature of this invention is to provide a method and the know-how relating to developing an all-natural/derived directly from naturally earth-occurring substances ingredient based dispersion of inorganic sun-block agents that will ensure an SPF value of at least 15 or greater. The dispersion itself must not have any endocrine disrupting agents or known toxins within the composition. The sunblock should also be translucent or transparent upon application to human skin. The compositions of the present inventive compositions include the use of test methods for determining whether there are any endocrine disrupting ingredients, active or inactive, in this sunscreen or sun-block compositions or any other composition. This includes adopting a test method (Applied-Kinesiology) for determining the
impact that the composition has on the wearer's neuro-muscular response. One adopted test method (LUMI-CELL) ensures that all ingredients used in the sunblock compositions, both active and inactive, are non-endocrine disrupting. In addition, the muscle testing diagnosis (of Applied-Kinesiology) can be used to determine the composition's effect upon the Neuro- muscular response and the combination of such is part of the present disclosure.
Another attribute of the invention includes meeting all ECOCERT standards for natural products. These standards provide impartial, independent scientific expertise ensuring reliability of claims to be 'all-natural' in regards to ingredients and formulations.
The foregoing objects and other features and advantages of the present invention are achieved by sunscreen and sun-block compositions containing inorganic sun-block agents or known non-endocrine disruptive sunscreen agents as the active ingredients. More particularly, the present invention relates to sun-block compositions containing zinc oxide and, optionally, titanium dioxide of preferred particle size ranges, and in preferred amounts and ratios. These sun-block agents together with preferably specifically cold-pressed aloe that contains an oligosaccharide of molecular weight of approximately 1-5,000 daltons that is glucose rich and also contains mannose which inhibits the loss of skin immuno-competency form the basis of a novel protective UV formulation. It has become evident that cold-processed aloe that is processed within 45 minutes of harvesting contains about 200 biologically active agents. The synergistic effect of all of these agents is desirable and preferred to further enhance the cytoprotective ability inherent in aloe plant extract.
These specific compositions of the present disclosure permit the use of much lower amounts of the sunscreen active ingredients than previously achievable while still achieving desired and very high SPF values for the compositions without the unsightly whiteness which occurs in prior sunscreen compositions. Concentrations of inorganic metal oxides above about 5% has heretofore presented whitening which to some consumers is unacceptable. In the sunscreen or sunblock compositions of this invention, considerably higher concentrations of zinc oxide and possibly titanium dioxide may also be used without incurring a whitening effect, e.g., even up to 25% each, with acceptable appearance.
Furthermore, our invention does not rely upon the use of hydrophilic titanium dioxide preparations nor are energy intensive processes such as powder milling, nor are organic active sunscreens required for high efficacy.
Instead, it is preferable to blend the inorganic metallic oxides with aloe barbadensis Miller (preferably aloe barbadensis- Miller-Stockton - a single species) and purified water (preferably deionized or distilled) to provide a dispersion that contains ingredients that are ecocertified and void of any known endocrine disrupters. The qualifications for ecocertification and a description of the ECOCERT standard are described in greater detail below.
The compositions of this invention include emulsions containing at least the following components:
a. an inorganic metallic oxide sun-block agent including glass microspheres; b. a non-endocrine disrupting or cytoprotective emulsifier or mixtures thereof ; c. a carrier oil component comprising an essential oil which is endocrine disruptive, with SPF boosting capabilities and; d. at least one emollient, where the emollient may be the cytoprotective emulsifier of (b) above or another constituent that allows for providing even spreading and film forming of the composition onto the skin and aids in keeping water from leaving the stratum corneum e. additional SPF boosting additives that are non-endocrine disruptors including gamma oryzanol.
The term 'cytoprotective' refers to the ability to protect cells from becoming pre-cancerous or cancerous.
The emollient is preferably aloe as it is "cold pressed" or an extract of aloe that is currently removed during normal processing and recovered by some means. The aloe or its extract may not provide sufficient emulsification based on the remaining ingredients of the composition. It has since been determined that a single species of aloe is preferred and best for providing a healthy and well dispersed product with the highest known concentrations of cytoprotective agents - aloe barbadensis Miller-Stockton. It is possible that the use of a natural product
such as; Polyglyceryl-3 Polyricinoleate , for example, Dermofeel ® PR, manufactured by Dr. Straetmans ® of Hamburg, Germany or Dermofeel ® GDI - glyceryl diisostearate, or Eumulgin SG - sodium stearoyl glutamate - and Emulgade PL 68/50 - a mixture of alkylpolyglucoside and cetyl stearyl alcohol and aribinogalactan and ethyl macadamiate) may all enhance the dispersion of the inorganic sun-block agents in the formulation and this is considered part of the present invention.
The compositions of this invention provide formulations having an SPF of at least 10, with titanium dioxide, zinc oxide, or a combination of the two (with or without silica or silicon dioxide and/or cosmetic microspheres), with either a coated or uncoated hydrophilic surface, at concentration levels of at least 4% and preferably at least 14% to reach SPF 15 or greater. The compositions of this invention exhibit extremely efficient uses of sunscreen components, particularly zinc oxide. Zinc oxide (INCI: zinc oxide) Absorbs both UVA and UVB rays of ultraviolet light and can be used in ointments, creams, and lotions to protect against sunburn and other damage to the skin caused by ultraviolet light. It is the broadest spectrum UVA and UVB absorber that is approved for use as a sunscreen by FDA, and is completely photostable. Additionally, since zinc oxide has antimicrobial and antifungal activities, it is the number one active ingredient recommended by pediatricians for the treatment of diaper rash. Alternatively, higher levels of preferably micronized titanium dioxide or zinc oxide can be used if ultramarine pigments are added to the composition. These pigments are known to eliminate the whiteness and poor spreadability of currently available compositions. For the purposes of this invention, however, these pigments must be known to be non-endocrine disruptive as well as to not interfere with the cytoprotective influence of the oligosaccharide aloe extract.
Because the invention makes use of uncoated particles (no surface treatment) of zinc oxide and/or titanium dioxide, unique formulation procedures must be followed to ensure proper dispersion. These inorganic agents must be either pre-dispersed in an oil before being added to the composition or added to a water base. Acceptable oils and dispersion methods are discussed below in the working examples. With proper dispersion and the use of ultramarine pigments, the compositions, after initial coloring effects, are substantially invisible upon application to the skin. Surface coated inorganic sunscreen can also be used, for example Z- cote HPl (ZnO coated with triethoxycaprylylsilane) and T-cote (TiO2 coated with Dimethicone). These coatings or surface treatments allow for easier dispersion (normally in
oil). However, because these coatings are objectionable to some consumers, compositions have been provided below with and without the use of surface treated ZnO and TiO2.
Thus, in one possible embodiment, the present invention is directed toward a colored sunscreen emulsion comprising: (a) at least one ultramarine pigment that imparts a color other than white to the emulsion with a titanium dioxide or zinc oxide or possibly fumed or fused silica or even silicon dioxide or micronized glass cosmetic spheres so that when the emulsion is rubbed into the skin, the color substantially disappears; (b) at least one sunscreen active agent in an amount effective to protect skin against the actinic radiation of the sun — this preferably being ZnO or Z-Cote (micronized particles - preferably nanoparticle sized to assure transparency); (c) no known or suspected endocrine disrupting organic substances; (d) a cytoprotective substance such as a glucose-rich mannose-containing oligosaccharide obtained from and used with aloe barbadensis Miller as the at least one emulsifϊer; and (e) sufficient water to form the other than a white colored emulsion; and sufficient dispersion to assure SPF of at least 15 and an SPF booster that shows no appreciable toxicity.
It is also noted that red raspberry seed oil and caneberry seed oil may be used as all natural SPF essential oils, hi the present disclosure an SPF of 30 or greater is enabled using red raspberry seed oil (in lieu of titanium dioxide) in a 4:1 ratio with ZnO (16%) concentration to raise the SPF of a base formulation to above SPF 30. With an 11% concentration of ZnO and red raspberry seed oil in a 4:1 ratio, a spray formulation with an SPF 22 was achieved. The amount of the ultramarine pigment in the composition can range from about 0 to about 25 weight percent of the composition, and preferably from about 1 to about 5 weight percent of the final formulation. Optionally, the sunscreen emulsion can contain one or more additional ingredients, including emollients, waterproofing agents, dry-feel modifiers, insect repellants, antimicrobial preservatives and/or fragrances.
The present invention is also directed towards a method for protecting the skin against sunburn while eliminating possible endocrine disruption response of human organs comprising topically applying the sunscreen formulation, as described above, to the skin.
An advantage of the present invention is that it provides a sunscreen and a method for protecting against sunburn that enables the user to apply the sunscreen more completely and uniformly to the skin, thus providing more effective protection against skin damage and
homogenously enhancing cytoprotection while eliminating endocrine disruptive organics, thus providing for long term health and safety in the presence of UV light.
Another advantage of the present invention is that it may provide a sunscreen with a color indicator which has a low fabric staining potential, and for which those stains that form can easily be removed from fabrics.
Still yet another advantage of the present invention is that it provides an optionally colored sunscreen and a method for protecting against sunburn that is more enjoyable for human use because of the attractiveness and appealing nature of the colored product which more closely matches the color of an individuals skin. For domesticated animals, the use of matching colors may also be appealing.
This invention allows for the use of ultrafine ZnO particles that are invisible when applied to human skin. This "invisible" ZnO would be the primary and perhaps only sunblock "active" ingredient or could be combined with titanium dioxide and silica or silicon dioxide and cosmetic microspheres to enhance dispersion and therefore provide a higher SPF value. These particles may be nanosized (<100 nm) or larger. Another embodiment of the disclosure is that formulations were developed with ZnO that have no surface treatments and that create stable emulsions. Stability was determined by putting samples in an oven at 40 C for four months which is equivalent to 4 years of shelf life.
The SPF booster agents may include; broccoli seed oil, pomegranate seed oil, castor oil, castor oil derivatives, including Castor Isostearate Succinate, gamma oryzanol, and all cane seed oils, specifically raspberry seed oil as well as the previously documented silicone oils. Toxicity is determined by Lumi-Cell testing described below.
DETAILED DESCRIPTION QF THE DISCLOSURE
The UV-protective compositions of this invention yield highly effective ultraviolet (UV) blocking capabilities. A typical titanium dioxide sunscreen composition of SPF 15 requires levels of titanium dioxide that impart a significant whitening effect to the skin; the compositions of this invention, minimize this disadvantage and are also economically viable to produce for commercial sale.
The composition of this invention include emulsions that are cosmetically superior to conventional inorganic preparations, including water-in-oil TiO2 formulations, at equivalent SPF ratings, due to the method and type of dispersion described within this disclosure. The compositions of this invention can be used for sun protection in casual daily wear or for facial products or in recreational situations. Because of the efficiency of the system, the inventive formulations are significantly better than any earlier developed compositions in that they do not allow for any endocrine disruptive agents to be included and meet or exceed the natural standards that the cosmetics industry is currently developing - including those of ECOCERT.
There are several ingredients that contribute to the unexpectedly high efficiency of the compositions blocking of UV radiation. The formulation of this invention is intended to filter harmful UVA as well as harmful UVB radiation so that the skin is fully protected. As each mammal's immuno-response system and skin composition is different, the required amounts required for application to the skin will vary. In addition, the actual UV protective formulation will vary based on the environmental location, length of exposure, age, health and other factors involving individual mammals, such that the concentrations of non- endocrine disruptive UVA screens, UVB screens, SPF boosting agents, inorganic pigments, and cytoprotective agents will vary.
A new and unique claim of this invention is that the invention not only protects the wearer from the harmful effects of the sun but actually strengthens the wearer's 'Neuro-muscular response'. One test method, 'Applied Kinesiology', has been used to test a user's neuro- muscular response to sunblock. Applied kinesiology (AK) is a form of diagnosis using muscle testing as a primary feedback mechanism to examine how a person's body is functioning. The compositions of the present invention have been tested according to this response and all patients have been "strengthened" in response to the inventive composition being applied to their skin. This science is still evolving and is not fully understood and the evidence is empirical, but this testing has been performed over the course of 2 years (2004- 2005) at Dr. John Schmitt's office (Triangle Wellness Center at 182 Wind Chime Ct. Ste. 203 Raleigh, North Carolina 27615) and is evidentiary of the fact that the composition is, in fact, "immuno-enhancing."
A more complete rating mechanism than the SPF rating method has already been suggested in US 6866841 filed August 9, 2001 and granted March 15, 2005, which is herein fully
Page 12 of 61
incorporated by reference. The immuno-response rating system could be a simple 0-10 value, with 10 indicating a substance within a UV-protective composition that is most beneficial to boosting skin cell immune responsiveness to carcinoma, melanoma, etc. (for instance).
What has also not been well considered by the cosmetics and associated sun-protection manufacturers industry is what the effect that certain agents, recently determined to be endocrine disrupters, may have on certain mammals, particularly humans, regarding the immune system response to UV radiation. Endocrines are essentially excretions from organs or glands. The organs or glands continually function by discharging waste or at the least exchanging fluids from an inlet side to an outlet side. Any disruption in the natural behavior of an organ or gland could have a deleterious effect on the ability of that organ or gland to continue to function normally and can depress immunofunctionality.
The industry currently formulates using "pre-fabricated" dispersions in that the dispersions are purchased from a secondary source and mixed in with existing lotions, pastes, cremes, etc. This technique is unacceptable and teaches away from this invention, in that the dispersions themselves contain endocrine disrupters and generally toxic (cell killing) chemicals so that manufacturers cannot claim an "all natural" composition. Therefore the ultimate UV-protective formulation would safely block or screen UV light, enhance the immune responsiveness of the skin in the absence or presence of UV, and ensure the user that there is no endocrine disrupting substance present.
Ease of application and cosmetic appeal, on the other hand, are also important in formulating sunscreen compositions. These characteristics rely on subjective evaluations such as visual and tactile impression by the user. Consumer research studies indicate that a sunscreen formulation should rub in easily, leave the skin non-sticky and, above all should be invisible or at least translucent on the skin after application. Sunscreen compositions containing organic sunscreen agents have been found, in some cases, to irritate the skin. Reduction of particle sizes of ZnO has resulted in microfine essentially clear ZnO when applied to the skin. Formulation in the family known as Z-Cote which is a trademarked composition sold by BASF is one such example of a micronized zinc oxide available today. (The process of micronization refers to breaking up a substance into particles that are only a few micrometers
in substance.) The groups of inorganic sun-block agents includes titanium dioxide, micronized titanium dioxide, zinc oxide, micronized zinc oxide, iron oxide, silicon dioxide, magnesium oxide, manganese oxide, silica, alumina, and aluminum oxides. Cosmetic microspheres, such as CM-111 AS produced by 3 M Corp of St. Paul, MN, can also be used as an inorganic sun-block agent.
In addition, the need for an acceptable emollient that reduces the negative affects associated with abrasive inorganics and that also includes the benefit of providing cytoprotection and healing of the skin is necessary. Allowing for the reduction of irritation or sensitization of the skin suggests that "cold-pressed" Aloe is a useful and necessary ingredient for such a UV- protective formulation. Essential oils can also provide this effect.
It has also been determined that it is quite difficult, if not impossible, for current dispersion systems for micronized TiO2, ZnO, SiO2 and the like to be endocrine-disruptor free. The endocrine disrupters in the Lumi-cell test technique have been found to kill cells. High speed shearing (accomplished in a Waring blender for example), followed by high speed mixing (up to 2000 rpm with an IKA mechanical stirrer for example) provides a consistent, usable, and easily blendable inorganic/organic dispersion free of any known toxic substances (if the aloe source and inorganic particle source is well documented and controlled). The dispersion is essential in providing sufficient homogeneity and SPF values with any associated non-active cream, lotion, gel, spray, lip balm, etc. that is used to provide a formulation consistent with the basis of the present invention.
To provide the proper SPF value, it is also necessary to enhance or boost the SPF number using boosting agents. These also may be neither endocrine disrupters nor toxic (cell- killing). It is likely that derivatives of other natural occurring substances (such as oils of safflower, sunflower, rice bran, eucalyptus, rosemary, peru balsam, olibanum, orange, almond, sesame, ylang ylang, jojoba, raspberry seed, pomegranate seed, or coconut) that can provide dispersion capabilities to enhance SPF - including cocoate esters (derived from coconut oil) may be determined to be free of endocrine disrupting capabilities.
Aloe Vera gel or juice, preferably at 100% concentration from whole filleted aloe leaves, serve numerous purposes in the present invention, including acting as a dispersant, as an emollient, boosting the SPF value, and improving aesthetics, and is believed by many to have
healthful benefits. For medicinal purposes, aloe vera is most commonly used externally to treat various skin conditions, and burns. Not only does it soothe the skin, ease pain and reduce inflammation, studies have been done to show that using aloe as a topical treatment for burns will help speed up the healing recovery process. Many cosmetic companies are now adding this plant to products including makeup, soaps, sunscreens, shampoos and lotions, as well as any product that is created to soothe, protect and moisturize the skin. This is due partially to the fact that aloe extract is full of vitamins, nutrients and minerals as well as biologically active substances including beneficial enzymes. Terry Labs ® of Melbourne, FL manufactures a 10X-40X aloe vera gel product which is usable in the present invention. 1OX is defined as 10 parts aloe to 90 parts water, while 4OX has four times the concentration of 10X, etc. However, IOOX gel is preferable, such as that produced by Aloe #1 Laboratories of Ft. Lauderdale, FL, which is obtained directly from the aloe filet.
There has been a growing need for a fast, reliable, inexpensive method to detect EDCs (endocrine disrupters) as reported in US patent 6866841 in the environment. As part of the present invention a fast, reliable, relatively inexpensive high throughput cell based recombinant bioassay screening method (LUMI-Cell™ ER bioassay) to determine the level of xenoestrogenic EDCs was reported.
This invention will meet all ECOCERT standards for natural products. ECOCERT is a control and certification organisation, whose activities are governed accordingly by the public authorities and legislation. ECOCERT is accredited for structure and procedures by COFRAC (French committee for accreditation), in accordance with guide standard ISO 65 (EN 45011), which requires independence, competence and impartiality. They work alongside associations to promote actions revolving around the environment and sustainable development. ECOCERT' s basic task consists in guaranteeing the rigorous respect of the applied standards on products, systems or services . The issuance of the certificate acts as a security for the consumer or the user. ECOCERT sets up standards in partnership with professionals, according to a tested methodology. These standards are based on objective and measurable criteria. ECOCERT insures the conception of a inspection plan, aiming at quality, origin and traceability. Adherence to the standard remains a free and voluntary approach, bearing quality and ethical values requirements. By means of the ECOLOGICAL AND ORGANIC COSMETICS standards, Ecocert defines a requirement level that is superior to
the conventional regulation governing cosmetics, thereby guaranteeing the genuine practice of environmental respect throughout the production line, respect for the consumer and the promotion of natural substances of a superior ecological quality.
ECOCERT requirements relate to ingredients, processes, suppliers of all raw materials, packaging, and labeling. ECOCERT standards do not allow synthetic perfumes or dyes, silicones, glycols, carbomers, parabens, phenoxyethanol, emulsifiers such as PEG, or solvents such as propylene glycol.
Components of the invention:
The compositions of this invention may, include one or more of a select group of anionic emulsifiers. In particular, salts of certain fatty acids are useful in the formulations of this invention, preferably salts of saturated fatty acids and/or salts of straight-chain fatty acids. Alkali metal salts, alkali earth metal salts and amine salts are more preferable for use in the compositions of this invention. For example, stearic acid and its salts are useful as emulsifiers in the compositions of this invention, while the use of isostearate salts tends to produce a composition which is not very efficient in the use of sunscreen. Sodium borate is an example of a preferred salt. Another potential emulsifier is glycerol oleate, and combinations thereof.
More particularly, it is the stearate or stearyl anionic emulsifiers that are useful in the compositions of this invention. While it is not fully understood why some salts of fatty acids result in an improved inventive composition, it is theorized that salts of straight-chain fatty acids, (the fatty acids having a relatively high melting point, above 70° C. or higher), are preferable due to their structure and how they resolve stearic hinderence and strain caused by introducing fine inorganic particles into polar and non-polar mediums.
The anionic emulsifiers should be present in the compositions of this invention in an amount from about 0.01 to about 10%, more preferably 0.1 to about 7% and most preferably from about 0.5 to about 5%. There may be additional emulsifiers present in the compositions of this invention. However it may or may not be necessary to include at least one anionic emulsifier in order to achieve the products of this invention. The fatty acid salt emulsifiers may be added to the composition as the salts, or the salt may be formed in situ.
A carrier oil is useful in the compositions of this invention. There are a range of different carrier oils each with their own individual properties and suitability towards different treatments in aromatherapy. Preferably, the carrier oil which is more preferably an essential oil, should be present in the composition in an amount of between about 0.5% and about 40%. More preferably, it should be present in the amount of between about 5% and about 30%. Most preferably, it should be present in the amount of between about 15% and about 28%. All essential oils are non-endocrine disrupting. Examples of essential oils include oils of raspberry seed (or any cane seed oil), pomegranate, jojoba, rice bran, sesame, safflower, almond, sweet almond, eucalyptus, sunflower, peru balsam, rosemary, olibanum, orange, sunflower, ylang ylang, coconut, apricot kernel, avocado, borage, cocoa butter, evening primrose, grapeseed, hazelnut, kukui, macademia nut, olive, peanut, pecan, rose hip, bergamot, jasmine, neroli, patchouli, petitgrain, rose, vetiver, chamomile, mandarin, lavender, grapefruit, cypress, bay laurel, frankincense, clary sage, ginger, helichrysum, lemon, sandalwood, basil, black pepper, peppermint, geranium, wintergreen, thyme, tea tree, tangerine, spearmint, common sage, rosewood, pine, patchouli, oregano, nutmeg, myrrh, melaleuca, marjoram, manuka, lemon grass, lavender, juniper, ginger, cumin, clove, camphor, bay leaf, anise, allspice, and hyssop.
For conventional UV-protection formulations, an oil phase should contain at least two materials, the carrier oil or essential oil and a conventional emollient known to those of ordinary skill in the art as useful in sunscreen products, such as mineral oils, ester oils, vegetable oils, and the like. For the present invention, the use of a cold pressed aloe barbadensis Miller and specifically the Stockton species is to be substituted as an emollient or can be used in combination with the oils or emollients that are proven to be non-endocrine disrupting as well as not interfering with augmenting the cytoprotective enhancing effects of the known effective oligosaccharide aloe extract. The emollient should be present in the formulation in a ratio to the carrier concentration of from about 1:1 to about 3:1, most preferably, about 2:1. The carrier oil and the emollient should compose from about 2% to about 40% of the total composition weight.
A third element which should be present in the compositions of this invention is an inorganic sunscreen compound, such as titanium dioxide, zinc oxide or combinations thereof. Possible other inorganics include the use of fused or fumed silica or even silicon dioxide. Preferably,
titanium dioxide, zinc oxide, silica, silicon dioxide, or cosmetic microspheres should be used having a primary particle size of less than about 300 nm in diameter. Larger diameter particles could be used but should be combined to make the product transparent or at least translucent. These inorganic compounds should be present in the composition in the amount of from about 2% to about 25%. More preferably, it should be present in the amount of from about 2% to about 15%. The inorganic sunscreen compound should be oil dispersible, and may be present with or without surface coating.
The ratio of titanium dioxide or zinc oxide to the weight of the carrier oil and the emollient combined should be from about 0.0: 1 to about 1 :1. More preferably, the ratio should be between about 0.25:1 and 2:3, and most preferably 1:0.25. The need for titanium dioxide may possibly be circumvented by the use of oils with SPF properties, such as red raspberry seed oil and pomegranate seed oil.
The base formulation of this invention may also be used as carrier compositions for active topical agents having dermatological effects, including depigmentation agents, anti-aging ingredients, anti-fungal agents, anti-microbial agents, insect repellents and the like. For example, depigmentation agents can include magnesium ascorbyl phosphate but only used in the final composition if shown not to be endocrine disrupters. Anti-aging agents can include retinoid compounds and alpha-hydroxy acids again only if these agents are shown not to be endocrine disrupters. Anti-fungal agents that can be included in the compositions of this invention include azole compounds including ketoconazole and the like again only if these agents are shown not to be endocrine disrupters. Anti-microbial agents include triclosan, an unknown agent regarding cytotoxicity or endocrine disruption function. Insect repellant fragrances can be included in the compositions of this invention again only if these agents are shown not to be endocrine disrupters. Other products known to those of ordinary skill in the art may be delivered to the skin using the compositions of this invention.
The compositions of this invention would then have minimally a multi-action capability, as they would contain both sunscreen/sunblocking agents and other actives for protecting, treating, and enhancing the immuno-responsive nature of the skin.
The compositions of this invention can be incorporated into various cosmetic and personal care products such as hand and body lotions, oils, ointments, lip balm products, facial cosmetics and the like.
One of the major challenges in providing the composition of the present invention is to provide a non-toxic (meaning on contact, the composition will not kill cells), non-endocrine disrupting, high (15 or greater) SPF formulation that can be readily achieved in a manufacturing environment for a reasonable cost. The use of aloe as both an emollient and a surfactant/dispersion agent together with either micronized ZnO, titanium dioxide, silicon dioxide, fluoropolymers, silica, etc. (inorganic or acceptable organic sun-block agents) in the manner outlined above is unique and novel. The addition of SPF boosting agents that are neither toxic nor endocrine disrupters is also unique to this invention and has heretofore not been seriously considered or explored when combined specifically with untreated metal oxide particle surfaces and also with certain treated surfaces of the same metal oxides.
The aloe (INCI: Aloe Barbadensis) and specifically single species of aloe, seems particularly well-suited (with and without the use of glycerin) to provide an emulsion that is homogeneous and can achieve sufficient SPF values using 14% or more (by weight) of the inorganic sun-block agents. Micronized sun-block agents are best for this emulsion as they provide the best surface area- volume ratio for proper wetting of the ZnO and other micronized inorganic/organic particles.
The use of green tea extract may be effective in reducing sunburn. Green tea inhibits UVB- induced erythema response in the skin (redness reaction). At the same time it supports the production of melanin, the skin's own natural sunburn protection. Thus green tea helps reduce the risk of sunburn and boosts SPF.
Sucrose stearate is usually a white or light brown block or powder, with little or no smell and no taste. It is an exceptionally mild emulsifϊer derived from sugar and coconut or palm oil. Sucrose stearate is made by combining sugar with stearic acid. Cane sugar is a sweetening agent and food which can act as a preservative and antioxidant, and stearic acid is a natural fatty acid derived from coconut or palm oil. Because it is made from vegetable sources it is completely biodegradable. One commercially available form of sucrose stearate is Crodesta
® F- 160, manufactured by Croda of Yorkshire, England. Esters of stearic acid are used to produce a pearly effect in shampoos, soaps, and other cosmetic products.
Hydrolyzed wheat protein is a protein from wheat which has been turned partly into water through hydrolysis.. Coconut oil (ENCI: Cocos nucifera (Coconut) Oil) is also excellent as a skin moisturizer. Hemp seed oil (INCI: Cannabis Satva (Sativa) Seed Oil) is used for the great effect it has on moisturizing and hydrating the skin, while bringing a host of other benefits such as recompensing for lower ceramide levels in the skin and thereby reducing the appearance of wrinkles.
Eumulgin® SG (INCI: Sodium Stearoyl Glutamate) is an anionic, powerful emulsifier especially interesting as it is EO-free and promotes the formulation of lamellar structures in oil/water emulsions when combined with suitable hydrophilic waxes. Due to the exceptional electrolyte compatibility Eumulgin® SG is key for concepts with high activity levels and / or water-soluble UV-filters.
Emulgade ® 68/50 (INCI: cetearyl alcohol & polyglucoside) is an ivory colored product with faint odor which is supplied in pellets. It is a non-ionic self-emulsifying base with consistency giving properties is suited for the preparation of cosmetic and pharmaceutical oil/water creams and lotions.
Lanolin is a thick natural moisturizer to soothe and protect skin. It is derived primarily from the oil glands in sheep's wool, also known as wool oil, wool wax, wool fat, or wool grease. Wool fat is a mixture of many different chemical compounds, including cholesterol and the esters derived from 'fatty' acids containing 18 to 26 carbon atoms. Lanolin is used in many skin formulas to prevent possible irritation from other oils. It functions as a salve and an emollient by sealing in your body's moisture, and is a natural water repellant. Lanolin forms an emulsion with water that's easily absorbed by the skin, softening it and preventing it from frying and cracking. It is used for dry skin, sunburn, and windburn, and may also boost SPF.
A number of oils are used in commercial sunblocks as SPF boosters. Such oils may be effective at boosting SPF on their own in some cases, or in combination with other oils in other cases. Among these oils are sunflower oil, safflower oil, almond oil, rice bran oil, eucalyptus oil, sesame oil, orange oil, jojoba oil, rosemary oil, peru balsam oil, grape seed oil,
coconut oil, red raspberry seed oil, black raspberry seed oil, pomegranate oil, etc. Certain waxes may also have a positive SPF effect, including beeswax, orange wax, and the like. Orange wax (INCI: Citrus Aurantium Dulcis (Orange) Peel Wax) has been found to be an excellent emollient, as well as containing phytosterols. These phytosterols are excellent co- emulsifiers which aid in stabilizing emulsions. Orange wax is also reputed to possess antimicrobial properties as well. Many silicone oils are suspected endocrine disrupters.
Beeswax is a product from a bee hive. Beeswax is secreted by honeybees of a certain age in the form of thin scales. It is a tough wax formed from a mixture of several compounds; Japan wax is another substitute.
Zenigloss® (INCI: Castor Isostearate Succinate, manufactured by Zenitech Corp ® of Old Greenwich, CT) is a natural liquid polymer of vegetable origin that is particularly suited for use in skin care products where an extended duration is desired such as liquid make-up products. It also provides good adhesion qualities for pigments and sunscreen films and when used in low solids emulsions it imparts a luxurious skin feel often associated with more expensive products. It has a high molecular weight which improves substantivity and puts gloss into a variety of applications and has pigment wetting and dispersion properties. Zenigloss serves in the present invention as an emulsifier and an SPF booster. It is natural and biodegradable and is easily formulated into finished products. Zenigloss UP is a natural polymer of vegetable origin used where reduced odor and taste are required. It is an excellent wetting/dispersing agent for inorganic microfine sunscreen particulates and it helps to improve adhesion of high SPF very water resistant sunscreen products and gloss.
Gamma Oryzanol (INCI: Orizynol) is a mixture of plant sterols and ferulic acid esters. Rice bran oil (INCI: Oryza sativa (Rice) Bran Oil) is the principal source of gamma oryzanol, but it is also found in the bran of wheat and other grains, as well as various fruits, vegetables, and herbs. The majority of gamma oryzanol used in nutritional supplements is harvested in Japan. It is also known as calclate, gamma-oz, gammariza, oryzanol, oz, and thiaminogen. Gamma Oryzanol has been proven to have very strong antioxidant activity. In fact, one study showed that it was up to ten times stronger than vitamin E for scavenging free radicals from the body and preventing tissue damage that results from free radical action. In the present invention, Gamma Oryzanol is used to increase the SPF value of the formulations without incorporating organic sunscreens. Vitamin C (INCI: Ascorbic acid) is a sugar acid with anti-oxidant properties. Ascorbate acts as an antioxidant.
Dermofeel ® PR (Polyglyceryl-3 Polyricinoleate) and Dermofeel® GDI. (Glyceryl Diisotearate), manufactured by Dr. Straetmans of Hamburg, Germany) is an oil component with good dispersability for color particles and an excellent adhesion strength. It is an non oxidizable, versatile applicable oil component of mediate to high viscosity. It is especially suitable to produce a resistant, long lasting film on the skin.
Ethyl Macadamiate (INCI: Ethyl Macadamiate) (for example, Floramac ® 10, by Floratech ® Americas of Chandler, Arizona) is the naturally derived ethyl ester of the free fatty acids produced by the complete saponification of Macadamia oil and offers excellent emolliency and skin feel. It is a dry emollient with high penetration, and has properties resembling silicone oil. Ethyl Macadamiate has SPF boosting properties and enhances the aesthetic pleasurability of the product. It serves as a substitute for silicon oil in the present invention. Unlike silicone oil, ethyl macadamiate is directly derived from naturally earth-occurring substances. Silicone oil is derived from synthetic components.
Arabinogalactin (INCI: Galactoarabinan) (for example, Laracare ® A200, manufactured by Lonza corp. of Basel, Switzerland) is a highly functional polysaccharide which serves as a natural, mild, non-irritating, readily biodegradable water soluble polymer capable of providing various benefits. It improves dispersion of inorganic sunscreen active ingredients and enhances SPF ratings. It provides film forming and skin tightening yielding an instant skin radiance and hair sheen effect. It also reduces transepidermal water loss (aids in moisturization). Studies have demonstrated its ability to minimize the appearance of fine lines and wrinkles, reduce transepidermal water loss (TEWL) and enhance alpha hydroxy acid (AHA) skin exfoliation without irritation.
To provide the proper consistency and aesthetics for the oil phase of the present invention, a dispersant is used. Possible acceptable dispersants include cocoate esters, (glyceryl cocoate ethoxylate, for example 'Washout' ® manufactured by Heritage Products of Virginia Beach, VA); Polyglyceryl-3 Polyricinoleate (e.g. Dermofeel ® PR, manufactured by Dr. Straetmans of Hamburg, Germany); or glyceryl cocoate (e.g. Imwitor ® 380, a partial glyceride of Caprylic, Capric, Citric, and Lactic acid, partially neutralized, or Imwitor ® 780k, a mixed ester of diglycerol with iso-stearic and succinic acid, manufactured by Sasol Olefins and Surfactants of Bad Homburg v.d. Hδhe, Germany).
Red Raspberry seed oil (INCI: Rubus Idaeus (Red Raspberry) seed oil) is a particularly functional oil in the present invention. Red raspberry seed oil possesses an exceptionally high proportion of alpha and gamma tocopherols (Vitamin E), vitamin A and omega-3 and omega- 6 fatty acids. Red raspberry seed oil offers the skin broad spectrum protection from damaging UV-A and UV-B rays. The SPF of red rapsberry seed oil has been found to be equal to that of titanium dioxide and has been rated to have an SPF as high as 28-50. Red raspberry seed oil has more pronounced anti-inflammatory properties than avocado (INCI: Persea gratissima (Avocado) Oil), grapeseed, hazelnut and wheatgerm oils and may prove to be most effective oil to use in the treatment of eczema, psoriasis and other skin conditions. Raspberry seed oil is also high in ellagic acid. Ellagic acid is a polyphenol antioxidant found in numerous fruits and vegetables. All caneseed oils exhibit some levels of ellagic acid and therefore are beneficial in the formulations of the compositions of the present disclosure.
Pomegrante oil is also beneficial in the present invention. Pomegranate seed oil nourishes, moisturizes and improves skin elasticity. Pomegranate seed oil is high in lipids including pucinic acid. Pomegranate seed oil can be effective in treating dry skin, eczema, psoriasis and sunburned skin. Its high polyphenol content makes it a strong anti-oxidant and adds to its stable shelf life. Pomegranate seed oil contains conjugated fatty acids which gives it strong anti-inflammatory properties and makes it a highly beneficial addition to formulations intended to reduce swelling and ease muscular aches and pains. Studies have shown that pomegranate oil is effective at killing cancer cells when applied topically.
Both arrowroot powder (INCI: Maranta Arundinacea) and tapioca starch (Manihot esculenta) are thickening agents. Their addition provides aesthetic and compositional benefits to the present invention. Arrowroot powder is the dried root of the arrowroot plant. It is a large perennial herb of genus Maranta found in rainforest habitats. Tapioca, also known as Cassava or Manioc, is a root or tuber extract. Its starch is found in the cells of the tubers.
Vitamin E oil (INCI: Tocopherol), is a fat-soluble vitamin in eight forms that is an important antioxidant. Vitamin E is often used in skin creams and lotions because it is believed to play a role in encouraging skin healing and reducing scarring after injuries such as burns. Natural vitamin E exists in eight different forms or isomers. Each form has its own biological activity, the measure of potency or functional use in the body. For the present invention, the most stable forms of Vitamin E are desired.
Beta Carotene is an anti-oxidant and as such can be useful for curbing the excess of damaging free radicals in the body. Beta-carotene is composed of two retinyl groups, and is broken down in the mucosa of the small intestine by beta-carotene dioxygenase to retinol, a form of vitamin A. Carotene can be stored in the liver and converted to vitamin A as needed, thus making it a provitamin. Carotene is an orange photosynthetic pigment and is responsible for the orange color of the carrot and many other fruits and vegetables. In the present invention it can serve an aesthetic purpose of enhanced coloration to improve transparency on the skin. Iron oxide can serve a similar purpose. Long-term supplementation with beta-carotene may reduce UV-induced erythema, and appears to modestly reduce the risk of sunburn in individuals who are sensitive to sun exposure.
Skin care products do not last forever. Just like food, all natural skin care products will eventually deteriorate. Chemical preservatives are generally used in the industry because they are much cheaper than, and extend the shelf life of the product more than, natural alternatives. The preferred preservative in the present invention is Biovert ®, a product of Arch Chemicals ®. Biovert® is a system of two linked preparations, which by themselves do not offer antimicrobial efficacy, but together offer anti-microbial efficacy. Biovert® mimics a naturally occurring antimicrobial-antioxidant protection system. When the two-part system is combined, a cascade of linked reactions takes place to generate antimicrobial products in situ. The cascade is initiated by the action of the glucose oxidase enzyme in the presence of its substrate (glucose) and oxygen. This generates H2O2, which is used by the lactoperoxidase to catalyze the oxidation of F and SCN" anions, forming hypoiodite and hypothiocyanate which have antimicrobial activity. The result is rapid microbial cell death. Other natural preservatives for use in the compositions of the present invention include tea tree and thyme essential oils, grapefruit seed extract (INCI: Citrus Grandis (Grapefruit) Seed Extract), and D- alpha Tocopherol Acetate (Vitamin E). Lactoperoxidase has been recognized as an effective antimicrobial and antibacterial agent.
One possible method for composing the sunblock composition of the present invention may be performed using a multi-vessel method, in which the oil and aloe or water phases are individually prepared. This process produces a smooth, uniform, white to light ivory emulsion that is satisfactory when the inorganic particles are sufficiently dispersed to provide desired SPF values. When uncoated inorganic sunscreen products are used, they must be pre- dispersed before addition into the composition. When combined with ultramarine pigments,
the color will change and may also provide a clear appearance (using the micronized inorganics) as the composition is applied to the skin.
In accordance with a two-vessel process, an aloe pre-mix ("phase A") is prepared by measuring aloe into a receptacle and mixing. Surface treated or untreated zinc oxide is sprinkled and mixed until free from lumps. A dispersant, such as glyceryl cocoate or Dermofeel ® or Eumulgin ® and Emulgade ® and aribinogalactan ® is added, as well as glycerin. The dispersant or emulsifier or emollient of the composite is added and mixed until completely uniform. The pre-mix is kept agitated and cool (room temperature or below) until use.
An oil pre-mix ("phase B") is prepared separately in another vessel. An oil, for example raspberry seed oil, is mixed with a dispersant (for example Dermofeel ®). This phase should be mixed with a homogenizer of preferably at least approximately 10,000 RPM until homogeneous. It is preferable to perform the mixing at room temperature or below.
In a separate vessel, the inorganic sunscreen materials are then dispersed into an oil, for example rice bran oil ("phase C"). This phase is homogenized until the sunscreen material is completely dispersed, while heating the compound to 80° C. The temperature should then be maintained at 80° C, while the contents phase B described above are added and homogenized into the composition. If a coated sunscreen product such as z-cote ® HP-I is used, this phase is unnecessary and the sunscreen material can be added during the oil phase described below.
The combined phases B and C are added to a clean, sanitized, and dry vessel, preferably stainless steel, with a sweep mixer and a rotosolver or equivalent high sheer mixing device (10,000 RPM) at 80° C. While the mixing device is operating, an "oil phase" is prepared by adding one or more of the following ingredients: one or more oils, a dispersant, and an emollient. Mixing should continue for 5-10 minutes until homogeneous, while temperature is maintained. One or more waxes and/or an emulsifier such as stearic acid is then added. Mixing should continue for 10-15 minutes. Hydrolyzed wheat protein can then be optionally added. Mixing continues for 5 minutes. Another emulsifier is then optionally added, for example sucrose stearate. Mixing continues at least another 5 minutes. Gamma oryzanol is optionally added and mixing continues for 15 minutes. SPF ingredients (e.g. glass microspheres, titanium dioxide) are optionally added and mixing continues for 15 minutes.
Beta Carotene and/or Vitamin E are optionally added, and mixing continues 5 minutes or until homogeneous.
A "water phase" is prepared in a separate vessel, preferably a clean, sanitized, and dry stainless steel vessel, equipped with a rotosolver or equivalent high shear mixing device (10,000 RPM). Deionized water is added and heated to 80° C. The following ingredients are added: glycerin, carrageenan, arabinogalactin, aloe, and/or the contents of "phase A" described above. The contents are mixed for 30 minutes or until homogeneous while maintaining temperature of 80° C.
When both the oil and water phases are homogeneous and at 80° C, a rotosolver (10,000 RPM) and sweep mixer in the oil phase are turned on. The water phase is slowly added to the oil phase while maintaining temperature. Mixing continues for 30 minutes or until homogeneous at 80° C. Additional aloe is optionally added, mixing for 10 minutes or until homogeneous. Thickeners such as arrowroot powder and/or tapioca starch are added, mixing 10 minutes or until homogeneous after each. Grapefruit seed extract is optionally added and mixed for 10 minutes or until homogeneous. Ascorbyl Palmitate, which is a fat-soluble form of vitamin C and can also used as an anti-oxidant food additive, is optionally added and mixed for 10 minutes or until homogeneous. Milk powder is optionally added and mixed for 15-20 minutes or until homogeneous. The rotosolver is turned off and the sweep mix set to low, as contents cool to 38-40° C. The rotosolver is then turned on and a preservative, such as Biovert ®, (glucose and lactoperoxidase and glucose oxidase) is added. When homogeneous, the rotosolver is turned off. Continue to sweep mix for 30 minutes or until homogeneous. Fragrance can then be added. Quality analysis can then be performed on the batch, and after proper storage of the compound, equipment can be cleaned for future batches.
It should be noted that for metal oxides with no surface treatment, the best method is to add the metal oxide to water with emulsifiers and then create a water in oil (w/o) system.
The industry currently formulates using "pre-fabricated" dispersions in that the dispersions are purchased from a secondary source and mixed in with existing lotions, pastes, cremes, etc. This technique is unacceptable and teaches away from this disclosure, in that the dispersions themselves contain generally toxic (cell killing) chemicals so that manufacturers should not claim an "all natural" composition. The present compositions are formulated using
homogenization, in part, to overcome this necessity as well as to provide higher SPF and proper texture of the finished composition.
Therefore the ultimate UV-protective formulation would safely block and/or screen UV light, enhance the immune responsiveness of the skin in the absence or presence of UV, and ensure the user that there is no toxic substance present.
Non-toxic SPF Boosting Agents
To provide the proper SPF value, it is also necessary to enhance or boost the SPF number using boosting agents. These boosting agents should also not be toxic (cell-killing). It is likely that many natural oils and perhaps derivatives of other natural occurring substances (such as essential oils of safflower, sunflower, rice bran, eucalyptus, rosemary, peru balsam, olibanum, orange, almond, sesame, ylang ylang, jojoba, or coconut) that can provide dispersion capabilities to enhance or boost SPF values may also be determined to be toxic free and are therefore also part of this disclosure. It has also been suggested that to increase SPF values for both in vivo and in vitro testing, film forming properties are important. The following film forming agents may also be used in the formulations and resulting compositions of the present disclosure: wheat protein extract, silk protein, galactoarabian, marine collagen, pea extract, purcellin oil, preen oil, and wild mango butter.
Bentonite can be used to boost SPF values. Colloidal Bentonite contains the active constituent montmorillonite super-refined with demineralized water as a vehicle. Aloe Vera gel serves numerous purposes in the present disclosure, including acting as a dispersant, as an emollient, boosting the SPF value, and improving aesthetics, and is believed by many to have healthful benefits.
Components of the disclosure
Other products known to those of ordinary skill in the art may be delivered to the skin using the compositions of this disclosure. Proper wetting is more readily achieved and results in long term stability when homogenization is employed.
Skin care products do not last forever. Just like food, all natural skin care products will eventually deteriorate. Chemical preservatives are generally used in the industry because they
are much cheaper than, and extend the shelf life of the product more than, natural alternatives.
All Examples listed below were developed as either oil in water (o/w) or water in oil (w/o) compositions that in most cases provide a stable final formulation. Specifically, without the use of surface treated zinc or titanium oxides, the challenge remains to provide a shelf stable (for >2 years) product with high SPF that uses only earth grown or earth derived components. This capability now exists and is specifically described in Examples I (a lotion using a surface treated ZnO), XXII (a spray using an untreated ZnO) and XXXIII (a lotion using an untreated ZnO).
EXAMPLE I
"Phase A" is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% uncoated Z-cote; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6 kg is prepared.
"Phase B" is prepared by mixing Dermofeel GDI ® (glyceryl diisostearate) and red raspberry seed oil in equal proportions. A total of 0.4 kg is prepared.
"Phase C" is prepared by mixing Z-cote and rice bran oil in a 1.5:2 ratio. 22 g of rice bran oil are homogenized with 16 g of z-cote, and the combination is homogenized at 80° C. "Phase B" is then homogenized into "Phase C" while maintaining temperature of 80° C.
The oil phase is prepared in a separate vessel. The combined phases B and C are mixed with a rotosolver (10,000 RPM) at 80° C. The following are added: 0.2 g coconut oil; 3 g raspberry seed oil; 4 g Zenigloss ® (Castor Isostearate Succinate); 3 g ethyl macadamiate. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2 g stearic acid; 0.2 g orange wax; 2 g beeswax. Mixing continues for 10-15 minutes at 80° C I g of wheat protein is added, and mixed for 5 minutes at 80° C I g of Crodesta F-160 (sucrose stearate) is added and mixed for 5 minutes at 80° C 0.2 g of gamma oryzanol is added and mixed for 15 minutes. Ig of beta carotene and 0.1 g of Vitamin E are added, and mixed for 5 minutes until homogeneous.
In a separate water phase, 20.87 mL of water are heated to 80° C. 3 g of glycerin are added, as well as the 0.6 kg of "phase A" described above and 0.3 kg of aloe gel 10OX, and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C. Mixing continues for 30 minutes. 3 g of aloe gel IOOX are added and mixed for an additional 10 minutes. 2 g of arrowroot powder is added and mixed for an additional 10 minutes. 0.16 g of tapioca starch is added and mixed for an additional 10 minutes. 1 g grapefruit seed extract is added and mixed for an additional 10 minutes. 0.1 g ascorbyl palmitate is added and mixed for an additional 10 minutes. 0.2 g milk powder is added and mixed for an additional 10 minutes. The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C. The rotosolver is turned back on for the addition of the preservative: 1 g of Biovert® substrate (glucose), and 0.05g Biovert® enzyme (lactoperoxidase glucose). When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
SPF (sun protection factor) can be measured as the ratio of the optical signal through the substrate without sunscreen divided by the optical signal through the substrate coated with the sunscreen. The system is calibrated against a series of sunscreens of known SPF (4 through 36) determined in-vivo using the FDA monograph method as of 8/25/1978. The resulting SPF of the composition of Example I above when measured in- vitro was 34.32 and the composition was aesthetically satisfactory and stable.
EXAMPLE II
"Phase A" is prepared with the following proportions: 71.43% Aloe (IOOX concentration); 7.14% uncoated Z-cote; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.3kg are prepared.
"Phase B" is prepared by mixing Dermofeel GDI ® (glyceryl diisostearate) and red raspberry seed oil in equal proportions. A total of 0.4 kg is prepared.
"Phase C" is prepared by mixing Z-cote and rice bran oil in a 1.5:2 ratio. 22g of rice bran oil are homogenized with 16g of z-cote, and the combination is homogenized at 80° C. "Phase B" is then homogenized into "Phase C" while maintaining temperature of 80° C.
The oil phase is prepared in a separate vessel. The combined phases B and C are mixed with a rotosolver (10,000 RPM) at 80° C. The following are added: 0.2g coconut oil; 3g raspberry seed oil; 5g Zenigloss ®; 3g ethyl macadamiate. The contents are mixed for 5-10 minutes at 80° C. The following are added: Ig stearic acid; 0.2g orange wax; 2g beeswax. Mixing continues for 10-15 minutes at 80° C Ig of wheat protein is added, and mixed for 5 minutes at 80° C Ig of sucrose stearate (Crodesta F- 160) is added and mixed for 5 minutes at 80° C 0.2g of gamma oryzanol is added and mixed for 15 minutes. 3g of glass microspheres are added and mixed for 15 minutes. O.lg of beta carotene and O.lg of Vitamin E Covoix-T are added, and mixed for 5 minutes until homogeneous.
In a separate water phase, 20.87 mL of water are heated to 80° C 3g of glycerin are added, as well as the 0.3kg of "phase A" described above and 0.3kg of aloe gel 10OX, and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C The water phase is then slowly added to the oil phase at 80° C Mixing continues for 30 minutes. 2g of arrowroot powder is added and mixed for an additional 10 minutes. 0.16g of tapioca starch is added and mixed for an additional 10 minutes. Ig grapefruit seed extract is added and mixed for an additional 10 minutes. O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes. The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C The rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
The resulting SPF of the composition of Example II above when measured in vitro was 32.29 and the composition was aesthetically satisfactory and stable.
EXAMPLE III
"Phase A" is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% uncoated Z-cote; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.3kg are prepared.
"Phase B" is prepared by mixing Dermofeel ® (glyceryl diisostearate) and red raspberry seed oil in equal proportions. A total of 0.4kg is prepared.
"Phase C" is prepared by mixing Z-cote and rice bran oil in a 1.5:2 ratio. 22g of rice bran oil are homogenized with 16g of z-cote, and the combination is homogenized at 80° C. "Phase B" is then homogenized into "Phase C" while maintaining temperature of 80° C.
The oil phase is prepared in a separate vessel. The combined phases B and C are mixed with a rotosolver (10,000 RPM) at 80° C. The following are added: 0.2g coconut oil; 3g raspberry seed oil; 6g Zenigloss ®; 3g ethyl macadamiate. The contents are mixed for 5-10 minutes at 80° C. The following are added: 0.2g orange wax; 2g beeswax. Mixing continues for 10-15 minutes at 80° C. Ig of wheat protein is added, and mixed for 5 minutes at 80° C. Ig of Crodesta F-160 is added and mixed for 5 minutes at 80° C. 0.2g of gamma oryzanol is added and mixed for 15 minutes. 3g of glass microspheres are added and mixed for 15 minutes. Ig of titanium dioxide (t-cote) is added and mixed for 15 minutes. 0.1 g of beta carotene and 0.1 g of Vitamin E are added, and mixed for 5 minutes until homogeneous.
In a separate water phase, 20.87 mL of water are heated to 80° C. 3g of glycerin are added, as well as the 0.3kg of "phase A" described above and 0.3kg of aloe gel 10OX, and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C. Mixing continues for 30 minutes. 2g of arrowroot powder is added and mixed for an additional 10 minutes. 0.16g of tapioca starch is added and mixed for an additional 10 minutes. Ig grapefruit seed extract is added and mixed for an additional 10 minutes. O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes. The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C. The rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes. The resulting SPF of the composition of Example III above when measured in vitro was 34.33 and the composition was aesthetically satisfactory and stable.
EXAMPLE IV
"Phase A" is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% uncoated Z-cote; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
"Phase B" is prepared by mixing Dermofeel ® and rice bran oil in equal proportions. A total of 0.4kg is prepared. "Phase B" is then homogenized with 0.16g of zinc oxide while maintaining temperature of 80° C.
The oil phase is prepared in a separate vessel. The phase B is mixed with a rotosolver (10,000 RPM) at 80° C. The following are added: 0.2g coconut oil; 2g jojoba oil; 2g pomegranate seed oil; 8g rice bran oil; 2g raspberry seed oil; 7g Zenigloss ®. The contents are mixed for 5- 10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax. Mixing continues for 10-15 minutes at 80° C Ig of wheat protein is added, and mixed for 5 minutes at 80° C. 1 g of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 0.2g of gamma oryzanol is added and mixed for 15 minutes. 5g of glass microspheres are added and mixed for 15 minutes. 0.0001 g of beta carotene and O.lg of Vitamin E Covoix-T are added, and mixed for 5 minutes until homogeneous.
In a separate water phase, 25.87 mL of water are heated to 80° C. 3g of glycerin are added, as well as the 0.6kg of "phase A" described above and 0.3kg of aloe gel 10OX, and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C. Mixing continues for 30 minutes. 4g of arrowroot powder is added and mixed for an additional 10 minutes. 0.16g of tapioca starch is added and mixed for an additional 10 minutes. Ig grapefruit seed extract is added and mixed for an additional 10 minutes. O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes. 0.2g milk powder is added and mixed for an additional 10 minutes. The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C. The rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
EXAMPLE V
"Phase A" is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% uncoated Z-cote; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
"Phase B" is prepared by mixing Dermofeel ® and red raspberry seed oil in equal proportions. A total of 0.4kg is prepared.
"Phase C" is prepared by mixing Z-cote and rice bran oil in a 1.5:2 ratio. 22g of rice bran oil are homogenized with 16g of z-cote, and the combination is homogenized at 80° C. "Phase B" is then homogenized into "Phase C" while maintaining temperature of 80° C.
The oil phase is prepared in a separate vessel. The combined phases B and C are mixed with a rotosolver (10,000 RPM) at 80° C. The following are added: 0.2g coconut oil; 2g raspberry seed oil; 7g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax. Mixing continues for 10-15 minutes at 80° C Ig of wheat protein is added, and mixed for 5 minutes at 80° C Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 0.2g of gamma oryzanol is added and mixed for 15 minutes. 0.000 Ig of beta carotene and O.lg of Vitamin E Covoix-T are added, and mixed for 5 minutes until homogeneous.
In a separate water phase, 20.87 mL of water are heated to 80° C 3g of glycerin are added, as well as the 0.6kg of "phase A" described above and 0.3kg of aloe gel 10OX, and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C The water phase is then slowly added to the oil phase at 80° C Mixing continues for 30 minutes. 4g of arrowroot powder is added and mixed for an additional 10 minutes. 0.16g of tapioca starch is added and mixed for an additional 10 minutes. Ig grapefruit seed extract is added and mixed for an additional 10 minutes. O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes. 0.2g milk powder is added and mixed for an additional 10 minutes. The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C The rotosolver is turned back on for the addition of the preservative: lg of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
Example VI
"Phase A" is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
The oil phase is prepared in a separate vessel. The following are added: 6g glyceryl cocoate ethoxylate; 0.2g coconut oil; 2g jojoba oil; 2g avocado oil; 1Og pomegranate seed oil; 7g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax. Mixing continues for 10-15 minutes at 80° C Ig of wheat protein is added, and mixed for 5 minutes at 80° C Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 0.2g of gamma oryzanol is added and mixed for 15 minutes. 4g of glass microspheres are added and mixed for 15 minutes. 16g of z-cote HPl is added and mixed for 15 minutes. Ig of titanium dioxide is added and mixed for 15 minutes. 0.000 Ig of beta carotene and O.lg of Vitamin E Covoix-T are added, and mixed for 5 minutes until homogeneous.
In a separate water phase, 23.87 mL of water are heated to 80° C 3g of glycerin are added, as well as the 0.6kg of "phase A" described above and 0.3kg of aloe gel 10X, and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C Mixing continues for 30 minutes. Ig of aloe gel 1OX is added and mixed for an additional 10 minutes. 4g of arrowroot powder is added and mixed for an additional 10 minutes. 0.16g of tapioca starch is added and mixed for an additional 10 minutes. Ig grapefruit seed extract is added and mixed for an additional 10 minutes. O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes. 0.2g milk powder is added and mixed for an additional 10 minutes. The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C The rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
Example VII
"Phase A" is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
"Phase B" is prepared with equal proportions of Dermofeel ® and rice bran oil. A total of 0.4kg is prepared.
The oil phase is prepared in a separate vessel. The following are added: The 0.4kg of phase B described above; 0.2g coconut oil; 2g jojoba oil; 2g pomegranate seed oil; 8g rice bran oil; 2g raspberry oil; 7g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax. Mixing continues for 10- 15 minutes at 80° C Ig of wheat protein is added, and mixed for 5 minutes at 80° C. Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 0.2g of gamma oryzanol is added and mixed for 15 minutes. 4g of glass microspheres are added and mixed for 15 minutes. 16g of z-cote HPl is added and mixed for 15 minutes. Ig of titanium dioxide is added and mixed for 15 minutes. O.OOOlg of beta carotene and O.lg of Vitamin E are added, and mixed for 5 minutes until homogeneous.
In a separate water phase, 25.87 mL of water are heated to 80° C. 3g of glycerin are added, as well as the 0.6kg of "phase A" described above and 0.3kg of aloe gel 10X, and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C. Mixing continues for 30 minutes. Ig of aloe gel 1OX is added and mixed for an additional 10 minutes. 4g of arrowroot powder is added and mixed for an additional 10 minutes. 0.16g of tapioca starch is added and mixed for an additional 10 minutes. Ig grapefruit seed extract is added and mixed for an additional 10 minutes. O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes. 0.2g milk powder is added and mixed for an additional 10 minutes. The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C. The rotosolver is turned back on for the addition of the preservative: lg ofBiovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
Example VIII
"Phase A" is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
"Phase B" is prepared with equal proportions of Dermofeel ® and rice bran oil. A total of 0.4kg is prepared.
The oil phase is prepared in a separate vessel. The following are added: The 0.4kg of phase B described above; 0.2g coconut oil; 2g jojoba oil; 8g raspberry oil; 7g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax. Mixing continues for 10-15 minutes at 80° C Ig of wheat protein is added, and mixed for 5 minutes at 80° C. Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 0.2g of gamma oryzanol is added and mixed for 15 minutes. 4g of glass microspheres are added and mixed for 15 minutes. 16g of z-cote HPl is added and mixed for 15 minutes. Ig of titanium dioxide is added and mixed for 15 minutes. 0.000 Ig of beta carotene and O.lg of Vitamin E are added, and mixed for 5 minutes until homogeneous.
In a separate water phase, 29.87 mL of water are heated to 80° C. 3g of glycerin are added, as well as the 0.6kg of "phase A" described above and 0.3kg of aloe gel 10X, and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C. Mixing continues for 30 minutes. Ig of aloe gel 1OX is added and mixed for an additional 10 minutes. 4g of arrowroot powder is added and mixed for an additional 10 minutes. 0.16g of tapioca starch is added and mixed for an additional 10 minutes. Ig grapefruit seed extract is added and mixed for an additional 10 minutes. O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes. 0.2g milk powder is added and mixed for an additional 10 minutes. The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C. The rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
EXAMPLE IX
"Phase A" is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
"Phase B" is prepared with equal proportions of Dermofeel ® and rice bran oil. A total of 0.4kg is prepared.
The oil phase is prepared in a separate vessel. The following are added: The 0.4kg of phase B described above; 0.2g coconut oil; 2g jojoba oil; 2g avocado oil; 1Og pomegranate seed oil; 7g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax. Mixing continues for 10-15 minutes at 80° C. Ig of wheat protein is added, and mixed for 5 minutes at 80° C Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 0.2g of gamma oryzanol is added and mixed for 15 minutes. 4g of glass microspheres are added and mixed for 15 minutes. 16g of z-cote HPl is added and mixed for 15 minutes. Ig of titanium dioxide is added and mixed for 15 minutes. 0.000 Ig of beta carotene and O.lg of Vitamin E are added, and mixed for 5 minutes until homogeneous.
In a separate water phase, 23.87 mL of water are heated to 80° C. 3g of glycerin are added, as well as the 0.6kg of "phase A" described above and 0.3kg of aloe gel 10X, and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C. Mixing continues for 30 minutes. Ig of aloe gel 1OX is added and mixed for an additional 10 minutes. 4g of arrowroot powder is added and mixed for an additional 10 minutes. 0.16g of tapioca starch is added and mixed for an additional 10 minutes. Ig grapefruit seed extract is added and mixed for an additional 10 minutes. O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes. 0.2g milk powder is added and mixed for an additional 10 minutes. The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C. The rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes. EXAMPLE X
"Phase A" is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
The oil phase is prepared in a separate vessel. The following are added: The 6g of glyceryl cocoate ethoxylate; 0.2g coconut oil; 2g jojoba oil; 2g avocado oil; 1Og rice bran oil; 7g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax. Mixing continues for 10-15 minutes at 80° C Ig
of wheat protein is added, and mixed for 5 minutes at 80° C Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 0.2g of gamma oryzanol is added and mixed for 15 minutes. 4.5g of glass microspheres are added and mixed for 15 minutes. 18g of z-cote HPl is added and mixed for 15 minutes. Ig of titanium dioxide is added and mixed for 15 minutes. 0.000 Ig of beta carotene and O.lg of Vitamin E Covoix-T are added, and mixed for 5 minutes until homogeneous.
In a separate water phase, 23.87 mL of water are heated to 80° C. 3g of glycerin are added, as well as theO.όkg of "phase A" described above and 0.3kg of aloe gel 10X, and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C. Mixing continues for 30 minutes. Ig of aloe gel 1OX is added and mixed for an additional 10 minutes. 4g of arrowroot powder is added and mixed for an additional 10 minutes. 0.16g of tapioca starch is added and mixed for an additional 10 minutes. Ig grapefruit seed extract is added and mixed for an additional 10 minutes. O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes. 0.2g milk powder is added and mixed for an additional 10 minutes. The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C. The rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
EXAMPLE XI
"Phase A" is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
The oil phase is prepared in a separate vessel. The following are added: The 3g of glyceryl oleate; 0.2g coconut oil; 2g jojoba oil; 2g avocado oil; 1Og broccoli seed oil; 7g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax. Mixing continues for 10-15 minutes at 80° C. Ig of wheat protein is added, and mixed for 5 minutes at 80° C. Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 0.2g of gamma oryzanol is added and mixed for 15 minutes. 4.5g of glass microspheres are added and mixed for 15 minutes. 18g of z-cote HPl is added and
mixed for 15 minutes. Ig of titanium dioxide is added and mixed for 15 minutes. 0.000 Ig of beta carotene and O.lg of Vitamin E are added, and mixed for 5 minutes until homogeneous.
In a separate water phase, 23.87 mL of water are heated to 80° C. 3g of glycerin are added, as well as the 0.6kg of "phase A" described above and 0.3kg of aloe gel 10X, and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C. Mixing continues for 30 minutes. Ig of aloe gel 1OX is added and mixed for an additional 10 minutes. 4g of arrowroot powder is added and mixed for an additional 10 minutes. 0.16g of tapioca starch is added and mixed for an additional 10 minutes. Ig grapefruit seed extract is added and mixed for an additional 10 minutes. O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes. 0.2g milk powder is added and mixed for an additional 10 minutes. The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C. The rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
EXAMPLE XII
"Phase A" is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
The oil phase is prepared in a separate vessel. The following are added: 3g of sunflower oil; 6g of glyceryl cocoate ethoxylate; 0.2g coconut oil; 2g of broccoli oil; 2g jojoba oil; 6g macadamia nut oil; 1Og Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 2g beeswax. Mixing continues for 10- 15 minutes at 80° C. 1 kg of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. Ig of glass microspheres are added and mixed for 15 minutes. 16g of z-cote HPl is added and mixed for 15 minutes. Ig of titanium dioxide is added and mixed for 15 minutes. 0.000 Ig of beta carotene and O.lg of Vitamin E Covoix-T are added, and mixed for 5 minutes until homogeneous.
In a separate water phase, 31.57 mL of water are heated to 80° C. 3g of glycerin are added, as well as the 0.6kg of "phase A" described above, and mixed with a rotosolver (10,000 RPM)
for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C. Mixing continues for 30 minutes. 0.3kg of aloe gel 1OX is added and mixed for an additional 10 minutes. Ig of sodium bicarbonate is added and mixed for an additional 10 minutes. 0.08g of tapioca starch is added and mixed for an additional 10 minutes. Ig grapefruit seed extract is added and mixed for an additional 10 minutes. O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes. 0.2g milk powder is added and mixed for an additional 10 minutes. The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C. The rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. Fragrance is then added: 0.2g rosemary; O.lg peru balsam oil; .02g frankincense. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
EXAMPLE XIII "Phase A" is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
The oil phase is prepared in a separate vessel. The following are added: 3g of sunflower oil; 6g of glyceryl cocoate ethoxylate; 0.2g coconut oil; 2g Zenigloss ® UP; 8g of broccoli oil; 2g avocado oil; 2g jojoba oil; 8g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 2g beeswax. Mixing continues for 10-15 minutes at 80° C. Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 3g of glass microspheres are added and mixed for 15 minutes. 16g of z-cote HPl is added and mixed for 15 minutes. 0.3g gamma oryzanol is added and mixed for 15 minutes. 1.5g of titanium dioxide is added and mixed for 15 minutes. 0.0001 g of beta carotene and O.lg of Vitamin E Covoix-T are added, and mixed for 5 minutes until homogeneous.
In a separate water phase, 25.77 mL of water are heated to 80° C. 3g of glycerin are added, as well as the 0.6kg of "phase A" described above, and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C. Mixing continues for 30 minutes. 0.1kg of aloe gel 1OX is added and mixed for an additional 10 minutes. Ig wood powder, Ig bentonite, and 2g of sodium bicarbonate are added and mixed for an additional 10 minutes. 0.08g of tapioca starch is added and mixed for an
additional 10 minutes. Ig grapefruit seed extract is added and mixed for an additional 10 minutes. O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes. 0.2g milk powder is added and mixed for an additional 10 minutes. The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C. The rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. Fragrance is then added: 0.2g rosemary; O.lg peru balsam oil; .02g frankincense. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
EXAMPLE XIV
"Phase A" is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
The oil phase is prepared in a separate vessel. The following are added: 3g of sunflower oil; 6g of glyceryl cocoate ethoxylate; 0.2g coconut oil; Ig Zenigloss ® UP; 4g of broccoli oil; 4g pomegranate seed oil; 2g jojoba oil; 6g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 2g beeswax. Mixing continues for 10-15 minutes at 80° C Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 2g of glass microspheres are added and mixed for 15 minutes. 18g of z-cote HPl is added and mixed for 15 minutes. 0.2g gamma oryzanol is added and mixed for 15 minutes. 0.000 Ig of beta carotene and O.lg of Vitamin E Covoix-T are added, and mixed for 5 minutes until homogeneous. Ig hydrolyzed wheat protein and mixed for 10 minutes until homogeneous.
In a separate water phase, 25.77 mL of water are heated to 80° C. 3g of glycerin are added, as well as the 0.6kg of "phase A" described above, and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C. Mixing continues for 30 minutes. 0.1kg of aloe gel 1OX is added and mixed for an additional 10 minutes.
Ig wood powder, 0.5g bentonite, and 0.5g of sodium bicarbonate are added and mixed for an additional 10 minutes. 0.08g of tapioca starch is added and mixed for an additional 10 minutes. 1 kg grapefruit seed extract is added and mixed for an additional 10 minutes. O.lg
ascorbyl palmitate is added and mixed for an additional 10 minutes. 0.2g milk powder is added and mixed for an additional 10 minutes. The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C. The rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. Fragrance is then added: 0.2g rosemary; O.lg peru balsam oil; .02g frankincense. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
EXAMPLE XV "Phase A" is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.3kg are prepared.
The oil phase is prepared in a separate vessel. The following are added: 6g of glyceryl cocoate ethoxylate; 5g Zenigloss ® UP; 5g of broccoli oil; 2g avocado oil; 5g pomegranate seed oil; 2g jojoba oil. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 2g beeswax. Mixing continues for 10-15 minutes at 80° C. Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 4g of glass microspheres are added and mixed for 15 minutes. 16g of z-cote FIPl is added and mixed for 15 minutes. 0.3g gamma oryzanol is added and mixed for 15 minutes. 0.000 Ig of beta carotene and O.lg of Vitamin E are added, and mixed for 5 minutes until homogeneous. Ig hydrolyzed wheat protein and mixed for 10 minutes until homogeneous.
In a separate water phase, 25.77 mL of water are heated to 80° C. 3g of glycerin are added, as well as the 0.3kg of "phase A" described above, and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C. Mixing continues for 30 minutes. 0.1kg of aloe gel 1OX is added and mixed for an additional 10 minutes. Ig wood powder, 2g of arrowroot powder, and Ig bentonite are added and mixed for an additional 10 minutes. 0.08g of tapioca starch is added and mixed for an additional 10 minutes. Ig grapefruit seed extract is added and mixed for an additional 10 minutes. O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes. 0.2g milk powder is added and mixed for an additional 10 minutes. The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C. The rotosolver is turned back on for the addition of the
preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incoφorated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
EXAMPLE XVI "Phase A" is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
The oil phase is prepared in a separate vessel. The following are added: 6g liquid lanolin; 0.2g coconut oil; 2g avocado oil; 1Og pomegranate seed oil; 2g jojoba oil; and 7g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax; and Ig sodium borate. Mixing continues for 10-15 minutes at 80° C. Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 4g of glass microspheres are added and mixed for 15 minutes. 16g of z-cote HPl is added and mixed for 15 minutes. Ig titanium dioxide is added and mixed for 15 minutes. 0.2g gamma oryzanol is added and mixed for 15 minutes. 0.000 Ig of beta carotene and O.lg of Vitamin E Covoix-T are added, and mixed for 5 minutes until homogeneous. 1 g hydrolyzed wheat protein and mixed for 10 minutes until homogeneous.
In a separate water phase, 22.87 mL of water are heated to 80° C. 3g of glycerin are added, as well as the 0.6kg of "phase A" described above, and 0.3kg aloe vera 1OX and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C. Mixing continues for 30 minutes. Ig of aloe gel 1OX is added and mixed for an additional 10 minutes. 4g of arrowroot powder is added and mixed for an additional 10 minutes. 0.16g of tapioca starch is added and mixed for an additional 10 minutes. Ig grapefruit seed extract is added and mixed for an additional 10 minutes. O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes. 0.2g milk powder is added and mixed for an additional 10 minutes. The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C. The rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
EXAMPLE XVII
"Phase A" is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
The oil phase is prepared in a separate vessel. The following are added: 6g Sasol Imwitor ® 360; 0.2g coconut oil; 2g avocado oil; 1Og pomegranate seed oil; 2g jojoba oil; and 7g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax; and Ig sodium borate. Mixing continues for 10-15 minutes at 80° C. Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 4g of glass microspheres are added and mixed for 15 minutes. 16g of z-cote HPl is added and mixed for 15 minutes. Ig titanium dioxide is added and mixed for 15 minutes. 0.2g gamma oryzanol is added and mixed for 15 minutes. 0.000 Ig of beta carotene and O.lg of Vitamin E Covoix-T are added, and mixed for 5 minutes until homogeneous. Ig hydrolyzed wheat protein and mixed for 10 minutes until homogeneous.
In a separate water phase, 22.87 mL of water are heated to 80° C. 3g of glycerin are added, as well as the 0.6kg of "phase A" described above, and 0.3kg aloe vera 1OX and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C. Mixing continues for 30 minutes. Ig of aloe gel 1OX is added and mixed for an additional 10 minutes. 4g of arrowroot powder is added and mixed for an additional 10 minutes. 0.16g of tapioca starch is added and mixed for an additional 10 minutes. Ig grapefruit seed extract is added and mixed for an additional 10 minutes. O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes. 0.2g milk powder is added and mixed for an additional 10 minutes. The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C. The rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
EXAMPLE XVIII
"Phase A" is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
The oil phase is prepared in a separate vessel. The following are added: 6g Sasol Imwitor ® 780K; 0.2g coconut oil; 2g avocado oil; 1Og pomegranate seed oil; 2g jojoba oil; and 7g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax; and Ig sodium borate. Mixing continues for 10-15 minutes at 80° C. Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 4g of glass microspheres are added and mixed for 15 minutes. 16g of z-cote HPl is added and mixed for 15 minutes. Ig titanium dioxide is added and mixed for 15 minutes. 0.2g gamma oryzanol is added and mixed for 15 minutes. 0.000 Ig of beta carotene and O.lg of Vitamin E Covoix-T are added, and mixed for 5 minutes until homogeneous. Ig hydrolyzed wheat protein and mixed for 10 minutes until homogeneous.
In a separate water phase, 22.87 mL of water are heated to 80° C. 3 kg of glycerin are added, as well as the 0.6kg of "phase A" described above, and 3g aloe vera 1OX and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C. Mixing continues for 30 minutes. Ig of aloe gel 1OX is added and mixed for an additional 10 minutes. 4g of arrowroot powder is added and mixed for an additional 10 minutes. 0.16g of tapioca starch is added and mixed for an additional 10 minutes. Ig grapefruit seed extract is added and mixed for an additional 10 minutes. O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes. 0.2g milk powder is added and mixed for an additional 10 minutes. The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C. The rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
EXAMPLE XIX
"Phase A" is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
The oil phase is prepared in a separate vessel. The following are added: 6g glyceryl cocoate ethoxylate; 0.2g coconut oil; 2g avocado oil; 3g pomegranate seed oil; 2g jojoba oil; and 14g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax; and Ig sodium borate. Mixing continues for 10-15
minutes at 80° C. Ig of Crodesta F-160 is added and mixed for 5 minutes at 80° C. 4g of glass microspheres are added and mixed for 15 minutes. 18g of z-cote HPl is added and mixed for 15 minutes. 1.5g titanium dioxide is added and mixed for 15 minutes. 0.2g gamma oryzanol is added and mixed for 15 minutes. 0.000 Ig of beta carotene and O.lg of Vitamin E Covoix-T are added, and mixed for 5 minutes until homogeneous. Ig hydrolyzed wheat protein and mixed for 10 minutes until homogeneous.
In a separate water phase, 22.87 mL of water are heated to 80° C. 3g of glycerin are added, as well as the 0.6kg of "phase A" described above, and 0.3kg aloe vera 1OX and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C. Mixing continues for 30 minutes. Ig of aloe gel 1OX is added and mixed for an additional 10 minutes. 4g of arrowroot powder is added and mixed for an additional 10 minutes. 0.16g of tapioca starch is added and mixed for an additional 10 minutes. Ig grapefruit seed extract is added and mixed for an additional 10 minutes. O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes. 0.2g milk powder is added and mixed for an additional 10 minutes. The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C. The rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
EXAMPLE XX
"Phase A" is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
The oil phase is prepared in a separate vessel. The following are added: 6g glyceryl cocoate ethoxylate; 0.2g coconut oil; 2g avocado oil; 1Og rice bran oil; 2g macadamia nut oil; 2g jojoba oil; and 7g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax. Mixing continues for 10- 15 minutes at 80° C. Ig of Crodesta F-160 is added and mixed for 5 minutes at 80° C. 4.25g of glass microspheres are added and mixed for 15 minutes. 17g of z-cote HPl is added and mixed for 15 minutes. 1.75g titanium dioxide is added and mixed for 15 minutes. 0.2g gamma oryzanol is added and mixed for 15 minutes. 0.000 Ig of beta carotene and O.lg of
Vitamin E Covoix-T are added, and mixed for 5 minutes until homogeneous. Ig hydrolyzed wheat protein and mixed for 10 minutes until homogeneous.
hi a separate water phase, 22.87 mL of water are heated to 80° C. 3g of glycerin are added, as well as the 0.6kg of "phase A" described above, and 0.3kg aloe vera 1OX and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C. Mixing continues for 30 minutes. Ig of aloe gel 1OX is added and mixed for an additional 10 minutes. 4g of arrowroot powder is added and mixed for an additional 10 minutes. 0.16g of tapioca starch is added and mixed for an additional 10 minutes. Ig grapefruit seed extract is added and mixed for an additional 10 minutes. O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes. 0.2g milk powder is added and mixed for an additional 10 minutes. The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C. The rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
EXAMPLE XXI
Phase A: (Water phase) is prepared with the following proportions: Pure aloe vera liquid/gel is prepared with 0.25% sodium bicarbonate and optionally 0.25% carrageenan. In a clean, sanitized and dry stainless steel vessel equipped with a homogenizer add, 69.95% pure aloe, 5.33% Glyceryl Cocoate, (a 50/50 blend of glycerine and glyceryl cocoate premixed at 80 deg C and mix until homogeneous). Phase B: (Oil Phase) In a clean, sanitized and dry stainless steel vessel equipped with a homogenizer add 2.67% - 3.67% Raspberry Seed Oil or Rice Bran Oil, optionally 1% Hemp Seed Oil and mix until homogeneous while heating (no greater than 80 degrees Cnetigrade). When Phase B is homogeneous and at the desired temperature (80 degrees Celsius or lower) add 3% Stearic Acid and mix until homogeneous. Continue mixing and cool Phase B to room temperature. Add 3% Ethyl Macadamiate, and mix until homogeneous.
When Phase B is homogeneous, add to Phase A. Mix (preferably with homogenizer) for 20- 30 minutes until homogeneous. (DO NOT allow batch to heat with mechanical heat from mixing-maintain at room temperature.) At room temperature add 0.5% Arabinogalactin and mix until homogeneous. Add 1% Biovert® Substrate, 0.05% Biovert® Enzyme, (Glucose &
Lactoperoxidase & Glucose Oxidase ) and up to 2.5% of a natural fragrance and mix for 20- 30 minutes until homogeneous, maintaining batch at room temperature. At room temperature, if necessary add another 2% pure aloe as described above. This final step may or may not be useful scale-up and for defoaming and viscosity control purposes.
EXAMPLE XXII (spray formulation of 9/14/07)
Phase A: (Water phase) is prepared with the following proportions: Pure Aloe is prepared with water to achieve a pH of 5.5. Sodium bicarbonate 0.5% may be used in the aloe. In a clean, sanitized and dry stainless steel vessel equipped with a homogenizer add, 49.95% Pure Aloe, 20.00% water, 11.00% Zinc Oxide Z-Cote (with no coating), 1.5% Eumulgin SG® (Sodium stearoyl glutamate) and 2% Emulglade PL68/50 ® (Cetearyl Glucoside & Cetearyl Alcohol) Mix until homogeneous.
Phase B: Oil Phase. In a clean, sanitized and dry stainless steel vessel equipped with a homogenizer add 2.67% Raspberry Seed Oil and 1% Hemp Seed Oil and mix until homogeneous while heating to 80 deg.C. When Phase B is homogeneous and at 80 degrees Celsius add 3% Stearic Acid, and mix until homogeneous. Continue mixing and cool Phase B to room temperature. Add 3% Ethyl Macadamiate and mix until homogeneous. When Phase B is homogeneous, add to Phase A and add 1.83% aloe. Mix with homogenizer for 20-30 minutes until homogeneous. (DO NOT allow batch to heat with mechanical heat from mixing-maintain at room temperature.) At room temperature add 0.5% Arabinogalactin and mix until homogeneous. Add 1% Biovert® Substrate, 0.05% Biovert® Enzyme and Fragrance, and mix for 20-30 minutes until homogeneous, maintaining batch at room temperature.
EXAMPLE XXIII Phase A: (Water phase) is prepared in this order: Heat to 60 deg.C. Add 14.75% water, 32.85% Aloe Juice w/carageenan and baking soda, 0.5% laracare A 200® (aribinogalactan), 3% Eumulgin SG®, 1% Emulgade PL68/50®, 16% Zinc Oxide, 1% hydrolyzed wheat protein, 1% hydrolyzed wheat protein, 0.1% vitamin E, 0.1% ascorbic acid - vitamin C, 0.1% orange wax, 0.5% beeswax and 0% beta carotene. Homogenize water phase at 60 deg.C.
Phase B: Oil Phase. Mix the following 2 ingredients together; 9% Rice Bran Oil and 0.2% Oryzinol. Heat to 70 C and slowly in order add the following while homogenizing: 5%
Raspberry seed oil, 0.1% Hemp Seed Oil, 4% Ethyl Macadamiate, 2% stearic acid, 4% Zenigloss® gloss and 0% coconut oil. Mix at 60 deg.C until homogenous. Add oil phase to water phase at 60 C then slowly add the remaining ingredients while cooling. Add in the following: 0.5% Arrowroot powder, 0.15% tapioca starch, 1% grapefruit seed extract, 0.1% ascorbyl plamitate, 1% glucose, 0.05% Lactoperoxidase and 2% all natural fragrance. Mix additional 20 minutes or until homogenous.
EXAMPLE XXIV
Phase A: (Water phase) Aloe/Zinc Pre-Mix. In a clean, sanitized and dry stainless steel vessel equipped with a homogenizer add, Pure Aloe. Pure aloe must be prepared as follows with water to neutralize the pH to 5.5 and 0.25% sodium bicarbonate in the aloe. Add 49.950 % aloe, 20% water, 11% zinc oxide Z-cote (no coating), 3.5% of 1.5% Eumulgin SG® or 2% Emulglade® PL68/50. Mix until homogeneous with 0.5% Aribinogalactan. Phase B: (Oil Phase) In a clean, sanitized and dry stainless steel vessel equipped with a homogenizer add 2.67% Raspberry Seed Oil, (or rice bran oil), 1% Hemp Seed Oil. Mix until homogeneous while heating to 80 deg.C. When Phase B is homogeneous and at 80 degrees Celsius add, 3% Stearic Acid. Mix until homogeneous. Continue mixing and cool Phase B to room temperature. Add 3% Ethyl Macadamiate, and Mix until homogeneous. When Phase B is homogeneous, add to Phase A and add 1.83% aloe. Mix with homogenizer for 20-30 minutes until homogeneous. (DO NOT allow batch to heat with mechanical heat from mixing-maintain at room temperature.) At room temperature add Arabinogalactin, (which was added earlier). Mix until homogeneous. Add 1% Biovert® Substrate, 0.05% Biovert® Enzyme, 2.5% Fragrance, and mix for 20-30 minutes until homogeneous, maintaining batch at room temperature. An additional step may or may not be necessary in scale-up. It is useful for defoaming and viscosity control purposes only.
EXAMPLE XXV
Phase A: (Water phase) Heat to 60 deg.C; 14.25% water, 32.35% Aloe Juice w/carageenan and baking soda, 0.5% laracare A 200, 3% Eumulgin SG®, 1% Emulgade PL68/50® , 16% Zinc Oxide, 1% hydrolyzed wheat protein, 1% Crodesta F 160, 0.1% vitamin E, 0.1% ascorbic acid - vitamin C, 0% beta carotene. Homogenize water phase at 60 deg.C. Phase B: (Oil phase) Mix the following 2 ingredients together; 9% Rice Bran Oil and 0.2% Oryzinol. Heat Rice Bran Oil and Oryzinol to 70 deg.C and slowly, in order, add the
following while homogenizing: 0% coconut oil, 5% Raspberry seed oil, 0.1% Hemp Seed Oil, 4% Ethyl Macadamiate, 2% stearic acid, 4% Zenigloss ®, 0.1% orange wax, 1% beeswax. Mix at 60 C until homogenous. Add oil phase to water phase at 60 deg.C then slowly add the remaining ingredients while cooling. 1.5% Arrowroot powder, 0.15% tapioca starch, 1% grapefruit seed extract, 0.1% ascorbyl plamitate, 1% glucose, 0.05% Lactoperoxidase, 1.5% all natural fragrance. Mix additional 20 minutes or until homogeneous. Cease mixing.
EXAMPLE XXVI Phase A: (Water phase) Heat to 60 deg.C; 14.75% water, 19.7% Whole leaf gel from Lilli of the Desert, 0.25% laracare A 200, 3% Eumulgin SG®, 1% Emulgade, 0% zinc oxide, 1% hydrolyzed wheat protein, 1% Crodesta F 160, 0.1% ascorbyl plamitate, 0.1% vitamin E, 0.1% ascorbic acid - vitamin C, 1% beta carotene, 0.1% orange wax, 1% beeswax. Homogenize water phase at 60 C. Phase B: (Oil phase) Mix the following 2 ingredients together; Ethyl Maccadamiate + zinc. Heat to 70 deg.C and slowly in order add the following while homogenizing: 0% coconut oil, 5.2% Rice Bran Oil w/oryzinol 9/0.20, 5% Raspberry seed oil, 0% Hemp Seed Oil, 0% Ethyl Macadamiate, 2% stearic acid, 4% Zenigloss ®, 38% zinc + ethyl macadamiate, Mix at 60 C until homogenous._Add oil phase to water phase at 60 deg.C then slowly add the remaining ingredients while cooling: 1.5% Arrowroot powder, 0.15% tapioca starch, 1 % grapefruit seed extract, 1% glucose, 0.05% Lactoperoxidase. Mix additional 20 minutes or until homogeneous. Cease mixing.
EXAMPLE XXVII Phase A: (Water phase) Heat to 60 deg.C; 14.75% water, 19.7% aloe juice w/baking soda, 0.25% laracare A 200, 3% Eumulgin SG®, 1% Emulgade, 0% zinc oxide, 1% hydrolyzed wheat protein, 1% Crodesta F 160, 0.1% ascorbyl plamitate, 0.1% vitamin E, 0.1% ascorbic acid - vitamin C, 1% beta carotene, 0.1% orange wax, 1% beeswax. Homogenize water phase at 80 deg.C. Phase B: (Oil phase) Mix the following 2 ingredients together; Ethyl Maccadamiate + zinc. Heat to 70 deg.C and slowly in order add the following while homogenizing: 0% coconut oil, 0% Rice Bran Oil w/oryzinol, 5% Raspberry seed oil, 0% Hemp Seed Oil, 5% Ethyl Macadamiate, 1% stearic acid, 4% Zenigloss ®, 38.2 % zinc rice bran oil + ORIZINOL. Mix at 60 deg.C until homogenous.
Add oil phase to water phase at 60 C then slowly add the remaining ingredients while cooling.
0.5% Arrowroot powder, 0.15% tapioca starch, 1% grapefruit seed extract, 1% glucose, 0.05% Lactoperoxidase. Mix additional 20 minutes or until homogeneous. Cease mixing.
EXAMPLE XXVIII
Phase A: (Water phase) Heat to 80 deg.C; 27.25% water, 24.7% aloe juice w/baking soda, 0.25% laracare A 200, 3% Eumulgin SG®, 1% Emulgade PL 68/50, 7% Zinc Oxide. 1% hydrolyzed wheat protein, 1% Crodesta F 160, 0.1% ascorbyl plamitate, 0.1% Viramin E, 0.1% ascorbic acid - vitamin C, 1% beta carotene, 0.5% orange wax, 1% beeswax. Homogenize water phase at 80 deg.C.
Phase B: (Oil phase) 0% coconut oil, 2.6% mixture of rice bran oil (2.5%) and oryzinol (0.1%), 16.5% raspberry seed oil, 0% hemp seed oil, 5% Ethyl Macadamiate, 1% stearic acid, 4% Zenigloss ®, 1% Avacado oil. Mix at 60 deg.C until homogenous. Add oil phase to water phase and increase temperature to 80 deg.C then slowly add the remaining ingredients while cooling. 0.25% Arrowroot powder, 0.1% tapioca starch, 0.5% grapefruit seed extract, 1% glucose, 0.05% Lactoperoxidase. Mix additional 20 minutes or until homogeneous.
EXAMPLE XXIX Phase A: (Water phase) Heat to 80 deg.C; 19.75% water, 24.7% aloe juice w/baking soda, 0.25% laracare A 200, 3% Eumulgin SG®, 1% Emulgade, 0% Zinc Oxide, 1% hydrolyzed wheat protein, 1% Crodesta F 160, 0.1% ascorbyl plamitate, 0.1% Viramin E, 0.1% ascorbic acid - vitamin C, 1% beta carotene. Homogenize water phase at 80 deg.C. Phase B: (Oil phase) Mix the following 2 ingredients together; Ethyl Maccadamiate + zinc. Heat to 70 degC and slowly in order add the following while homogenizing: 0% coconut oil, 2.6% mixture of rice bran oil (5%) and oryzinol (1%), 21% raspberry seed oil, 0% hemp seed oil, 5% Ethyl Macadamiate, 1% stearic acid, 1% orange wax, 2% bees wax, 4% Zenigloss ®, 1% Avacado oil. Mix at 80 deg.C until homogenous. Add oil phase to water phase at 80 deg.C then slowly add the remaining ingredients while cooling. 2% Arrowroot powder, 3% tapioca starch, 1% grapefruit seed extract, 1% glucose, 0.05% Lactoperoxidase. Mix additional 20 minutes or until homogeneous. Cease mixing.
EXAMPLE XXX
Phase A: (Water phase) Heat to 80 deg.C; 27.25% water, 24.7% aloe juice w/baking soda, 0.25% laracare A 200, 3% Eumulgin SG®, 1% Emulgade PL68/50®, 7% Zinc Oxide, 1% hydrolyzed wheat protein, 1% Crodesta F 160, 0.1% ascorbyl plamitate, 0.1% Viramin E, 0.1% ascorbic acid - vitamin C, 1% beta carotene, 0.5% orange wax, 1% beeswax. Homogenize water phase at 80 deg.C.
Phase B: (Oil phase) 0% coconut oil, 2.6% mixture of rice bran oil (2.5%) and oryzinol (0.1%), 16.5% raspberry seed oil, 0% hemp seed oil, 5% Ethyl Macadamiate, 1% stearic acid, 4% Zenigloss ®, 1% Avacado oil. Mix at 60 deg.C until homogenous. Add oil phase to water phase at 80 C then slowly add the remaining ingredients while cooling: 0.25% Arrowroot powder, 0.1% tapioca starch, 0.5% grapefruit seed extract, 1% glucose, 0.05%
Lactoperoxidase. Mix additional 20 minutes or until homogeneous. Cease mixing.
EXAMPLE XXXI
Phase A: (Water phase) Heat to 80 deg.C; 19.75% water, 24.7% aloe juice w/baking soda, 0.25% laracare A 200, 3% Eumulgin SG®, 1% Emulgade, 0% Zinc Oxide, 1% hydrolyzed wheat protein, 1% Crodesta F 160, 0.1% ascorbyl plamitate, 0.1% Vitamin E, 0.1% ascorbic acid - vitamin C, 1% beta carotene, 1% orange wax, 2% beeswax. Homogenize water phase at 80 deg.C. Phase B: (Oil phase) 0% coconut oil, 6% mixture of rice bran oil (5%) and oryzinol (1%), 21% raspberry seed oil, 0% hemp seed oil, 5% Ethyl Macadamiate, 1% stearic acid, 4% Zenigloss ®, 1% Avacado oil. Mix at 60 deg.C until homogenous. Add oil phase to water phase at 80 C then slowly add the remaining ingredients while cooling: 2% Arrowroot powder, 3% tapioca starch, 1% grapefruit seed extract, 1% glucose, 0.05% Lactoperoxidase. Mix additional 20 minutes or until homogeneous. Cease mixing.
EXAMPLE XXXII
Phase A: (Water phase) Heat to 80 deg.C; 27.25% water, 24.7% aloe juice w/baking soda, 0.25% laracare A 200, 3% Eumulgin SG®, 1% Emulgade, 7% Zinc Oxide, 1% hydrolyzed wheat protein, 1% Crodesta F 160, 0.1% ascorbyl plamitate, 0.1% Viramin E, 0.1% ascorbic acid - vitamin C, 0% beta carotene, 0.5% orange wax, 1% beeswax. Homogenize water phase at 80 deg.C.
Phase B: (Oil phase) 0% coconut oil, 2.6% mixture of rice bran oil (2.5%) and oryzinol (0.1%), 16.5% raspberry seed oil, 0% hemp seed oil, 5% Ethyl Macadamiate, 1% stearic acid, 4% Zenigloss ®, 1% Avacado oil. Mix at 60 deg.C until homogenous. Add oil phase to water
phase at 80 C then slowly add the remaining ingredients while cooling: 0.25% Arrowroot powder, 0.1% tapioca starch, 0.5% grapefruit seed extract, 1% glucose, 0.05% Lactoperoxidase, 1.5% Emulgen, 1% Ethyl Macadamiate. Mix additional 20 minutes or until homogeneous. Cease mixing.
EXAMPLE XXXIII Phase A: (Water phase) Heat to 80 deg.C; 42015% water, 16.75% aloe juice w/baking soda, 4% Eumulgin SG®,, 2% Emulgade PL68/50, 16% Zinc Oxide, 0% hydrolyzed wheat protein, 0% Crodesta F 160, 0 % ascorbyl plamitate, 0.1% Viramin E, 0.1% ascorbic acid - vitamin C, 0.1% beta carotene, 0.25% orange wax, 0.5% beeswax. Homogenize water phase at 80 degC.
Phase B: (Oil phase) 1% Avacado oil, 1% mixture of rice bran oil (0.95%) and oryzinol (0.05%), 4% raspberry seed oil, 3% stearic acid, 6.5% ethyl maccadamiate. Mix at 80 deg.C until homogeneous. Add oil phase to water phase at 80 C then slowly add the remaining ingredients while cooling: 0.5% Laracare A200, 1% grapefruit seed extract, 1% glucose, 0.05% Lactoperoxidase. Mix additional 20 minutes or until homogeneous. Cease mixing.
EXAMPLE XXXIV
26.30 ml of deionized water was added to a receptacle. 20.0 grams of Cold Pressed Aloe,
1.75 grams of vegetable glycerin, and 0.25 grams of grapefruit seed extract were mixed into the water. 0.35 g of Xanthan gum was added to the receptacle, with good mixing, until all ingredients were dissolved. The mixture was heated to 40° C. In a second receptacle, 19.2 g of rice bran oil mixed together with 3.5 g of dispersed phosphatidyl choline, 7.0 g of suitable carrier such as castor oil, avocado oil, broccoli seed oil, keratin, micronized or colloidal bentonite, etc. (essential oils or equivalent SPF boosting agents can be used including broccoli seed oil, pomegranate seed oil, and castor oil derivatives such as castor isostearate succinate as well as the previously documented silicone oils. Next, 0.1 g of orange wax, and 2.5 g of beeswax were mixed until all solids were dissolved, and the mixture was heated to 65° C. When the solution of the second receptacle was heated and became homogenous, 12.0 grams of micronized zinc oxide (Z-Cote ®), 4.8 grams of natural source tocopherol (D- alpha), and 4.8 grams of T-Cote ® are added to this second receptacle requiring good agitation and maintaining temperature until the micronized powders were properly wetted. A high-energy mixer was used to disperse the ingredients. The first receptacle (water phase) was then added to the second receptacle (oil phase) with high-speed mixing. On a small scale
(less than 200 grams), the addition of phases has been successfully reversed. Mixing continued until the composite was cooled. To this mixture, 1.0 gram of Biovert® substrate (a product of Arch Chemicals and a composite of glucose, lactoperoxidase, and glucose oxidase) was then added, mixing thoroughly. 0.05 grams of Biovert® enzyme was added. The receptacle was mixed until smooth and homogenous.
Claims
1. A composition comprising;
(a) at least one inorganic metallic oxide sun-block agent without surface treatment dispersed in either water, aloe, oil, or alcohol, or any combination of water, aloe, oil and alcohol;
(b) at least one a non-endocrine disrupting or cytoprotective emulsifier or mixtures thereof ;
(c) at least one carrier oil component comprising an essential oil which is non-endocrine disrupting with SPF boosting capabilities;
(d) at least one emollient, where the emollient may be the cytoprotective emulsifier of (b) above or a different constituent that allows for providing even spreading and film forming of the composition onto the skin and aids in keeping water from leaving the stratum corneum and;
(e) additional SPF boosting additives that are non-endocrine disruptors including gamma oryzanol wherein said composition is derived directly from only naturally earth occurring substances and provides transparent or translucent or color matching appearance when applied to skin and wherein said composition provides a shear thinning fluid causing lower viscosity thereby enabling spraying of the composition through a spray nozzle.
2. The composition of claim 1, wherein said water is purified using ozonation, ionization, or distillation or any combination thereof wherein alcohol may be substituted for, or combined with water; and said at least one emollient includes but is not limited to chitosan or aloe vera gel, individually or in any combination; and wherein said carrier oil is a non-toxic SPF boosting component that optionally includes but is not limited to additional components comprising; non-toxic silicone oil, ethyl macadamiate, butter milk, waxes impregnated with inorganic sun-block or sunscreen agents, organic/inorganic micronized particles, wood powder, bentonite clay or clay dispersions, keratin, broccoli seed oil, pomegranate seed oil, castor oil, castor oil derivatives, including castor isostearate succinate or glyceryl diisotearate, or any cane seed oil individually or in any combination of said additional components; and wherein said at least one inorganic sun-block or sunscreen agent includes any metal oxide, glass microsphere, silica and silica compound, and optionally metal oxide pigments with particles that are micronized, submicronized, nanoparticle sized, that individually or in any combination can be homogenized in either a water phase, a water-aloe phase, or an oil phase or any phase of said composition; and wherein said at least one emulsifier wherein said emulsifϊer includes but is not limited to a phospholipid and/or liposome or an aloe vera gel or an ester of coconut oil individually or in any combination, for emulsifying said water, water- aloe, or said oil phase in combination with an homogenizer; and wherein any of said components are preferably mixed with an homogenizer and wherein an appropriate thickening agent including xanthan gum, carageenan, either individually or in any combination is added as required.
3. The composition of claim 1, comprising:
(a) at least one ultramarine pigment that imparts a color other than white to the emulsion with a titanium dioxide or zinc oxide or fumed or fused silica or silicon dioxide or micronized glass cosmetic spheres so that when said composition is rubbed into the skin, the color of said composition substantially disappears into said skin;
(b) non-endocrine disrupting organic carrier liquids or oils;
(c) sufficient water to form the other than a white colored emulsion; and (d) sufficient dispersing agents and associated mixing to assure SPF of at least 15 using a non-toxic SPF booster.
4. The composition of claim 1, comprising initially a three phase system wherein phase A comprises 71.43% cold pressed aloe vera gel or juice, 7.14% zinc oxide, 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin for a total of 0.6 kilograms on a 1000 gram basis, phase B comprises glyceryl diisostearate and red raspberry seed oil in equal proportions for a total of 0.4 kilograms on a 1000 gram basis and phase C is prepared by mixing zinc oxide and rice bran oil in a 1.5:2 ratio so that 22 g of rice bran oil are homogenized with 16 g of zinc oxide, wherein phase B is homogenized with phase C into a new single oil phase while maintaining a temperature of no more than 80° Centigrade and wherein 0.2 g coconut oil; 3 g raspberry seed oil; 4 g castor isostearate succinate; 3 g ethyl macadamiate are added to said new single oil phase and subsequently 2 g stearic acid; 0.2 g orange wax; 2 g beeswax; 1 g of wheat protein; 1 g of sucrose stearate ; 0.2 g of gamma oryzanol; Ig of beta carotene and 0.1 g of Vitamin E are added, and mixed until homogeneous and in a separate new water phase comprising 20.87 mL of water heated to no greater than 80° C; 3 g of glycerin; 0.6 kilograms of phase A and 0.3 g of aloe is mixed and wherein said separate new water phase is added and mixed with said new single oil phase wherein 3 g of aloe, 2 g of arrowroot powder, 0.16 g of tapioca starch, 1 g grapefruit seed extract, 0.1 g ascorbyl palmitate, and 0.2 g milk powder are added and mixed until homogenous and finally 1 g of glucose/glucose oxidase and 0.05 g of lactoperoxidase glucose are added and mixed until homogenous followed by sweep mixing for 30 minutes resulting in an SPF value of greater than 30.
5. The composition of claim 1, wherein said sun-block agents comprise zinc oxide, micronized zinc oxide, including Z-Cote® or any combination thereof or wherein said sunblock agents comprise titanium dioxide, micronized titanium dioxide, including T-Cote® or any combination thereof and wherein said emollient comprises cocoate ester (glyceryl cocoate ethoxylated), Dermofeel ® PR or GDI, Imwitor ® 380, Imwitor ® 780k, or combinations thereof and wherein thickening agents comprise xanthan gum, carrageenan, arrowroot powder, tapioca starch, wood powder, bentonite, or combinations thereof and wherein said SPF boosting additives comprise coconut oil, orange wax, beeswax, jojoba oil, rice bran oil, sesame oil, safflower oil, almond oil, sweet almond oil, eucalyptus oil, sunflower oil, grape seed oil, hazelnut oil, macadamia oil, rose oil, mandarin oil, chamomile oil, ginger oil, lemon oil, sandalwood oil, basil oil, peppermint oil, hyssop oil, raspberry seed oil or any caneseed oil, pomegranate seed oil, broccoli seed oil, or mixtures thereof and wherein said oil comprises coconut oil, jojoba oil, rice bran oil, sesame oil, safflower oil, almond oil, eucalyptus oil, sunflower oil, sweet almond oil, grape seed oil, avocado oil, olive oil, evening primrose oil, walnut oil, peanut oil, macadamia nut oil, raspberry seed oil, pomegranate seed oil, broccoli seed oil, or mixtures thereof.
ό.The composition of claim 1, wherein said microspheres are Sensient Cosmetic Microspheres ® CM-111 and wherein anti-oxidants can be added to said composition said antioxidants comprising beta carotene, beta Glucan, green tea extract, grapefruit seed extract, grape seed extract, grape seed oil, or mixtures thereof and wherein said sucrose stearate is Crodesta® F- 160.
7. The composition of claim 1, wherein the amount of sun-block agent and necessary SPF boosting agents, if any, is increased until the composition has an SPF value of at least 15.
8. The method of claim 4 wherein said sun-block agents comprise iron oxide, silicon dioxide, magnesium oxide, manganese oxide, silica, alumina, aluminum oxides, cosmetic microspheres, or combinations thereof.
9. The composition of claim 1, wherein preservatives comprise Biovert ® enzyme, Biovert ® substrate, glucose, lactoperoxidase, glucose oxidase, or mixtures thereof.
10. The composition of claim 1 wherein said essential oils comprise oils of broccoli, raspberry seed, pomegranate seed, avocado, macadamia nut, rosemary, peru balsam, olibanum, orange, sunflower, safflower, almond, sesame, rice bran, ylang ylang, eucalyptus, jojoba, coconut, allspice, anise, basil, bay leaf, bergamot, camphor, cedar, celery, chamomile, cassia, citronella, cinnamon, clary sage, clove, cumin, geranium, ginger, grapefruit, hyssop, jasmine, juniper, lavender, lemon, lemon grass, manuka, marjoram, melaleuca, myrrh, nutmeg oil, oregano, patchouli, peppermint, pine, rose, rosewood, common sage, sandalwood, spearmint, tangerine, tea tree, thyme, wintergreen or mixtures thereof.
11. The composition of claim 1, wherein phospholipids can be used as or with said emollients and wherein said phospholipids comprise phosphotidyl choline, Phospholipon 9OG, Phospholipon 85 G, Phospholipon 9OH, Phospholipon 10OH, individually or any mixture thereof and wherein said phospholipid is phosphotidyl choline dissolved in aloe vera, wherein petouli oil maybe optionally added and wherein said phospholipid dissolved in an oil or aloe vera or water or any combination thereof and wherein Phosphatidyl-choline (PC), a phospholipid also known as lecithin and PhosChol, can be used as a natural dispersant and/or emulsifier and wherein the major component of a phosphatide fraction may be isolated from either egg yolk or soy beans and may be mechanically or chemically extracted using hexane.
12. The composition of claim 1 wherein said composition has a pH of at least 5.
13. The composition of claim 1 homogenized with a mixture comprising Beeswax, coconut oil, sunflower oil, tocopherol acetate & tocopherol, peppermint oil, comfrey root extract, rosemary extract, or mixtures thereof.
14. The composition of claim 1 wherein the amount of water and aloe vera are increased until the viscosity of the composition is low enough to be sprayed through a nozzle.
15. The composition of claim 1 wherein said emulsifier is Zenigloss, Zenigloss UP, or combinations thereof and wherein said arabinogalactin is Laracare A200.
16. A lotion or spray composition comprising; a water phase prepared in the following proportions by weight; 49.95 % pure aloe, and 20% purified water to achieve a pH of 5.5 with 0.5% sodium bicarbonate added to said aloe and 11.0% zinc oxide together with 1.5% sodium stearoyl glutamate and 2% cetearyl glucoside and cetearyl alcohol, 0.1% Vitamin E, 0.1% ascorbic acid, 0.1% beta carotene, 0.25% orange wax and 0.5% beeswax and wherein said water phase is mixed and cooled and heated until homogeneous and an oil phase is prepared in the following proportions by weight; 2.67% -3.67 % raspberry seed oil and up to 1% hemp seed oil plus 3% stearic acid, and 3% ethyl macadamiate wherein said oil phase is mixed and heated and cooled until homogenous and wherein said oil phase is added to said water phase with an additional 1.83% aloe followed by mixing and cooling and subsequent addition of 0.5% arabinogalactin 1 % of glucose/glucose oxidase and 0.05 % of lactoperoxidase glucose, optionally fragrance followed by mixing until homogeneous said composition resulting in a stable product with an SPF value of greater than 20.
17. A lotion comprising a water phase prepared in the following proportions by weight; 16.75 % pure aloe, and 42.015% purified water to achieve a pH of 5.5 with 0.5% sodium bicarbonate added to said aloe and 16.0% zinc oxide together with 4% sodium stearoyl glutamate and 2% cetearyl glucoside and cetearyl alcohol, 0.1% Vitamin E, 0.1% ascorbic acid, 0.1% beta carotene, 0.25% orange wax, and 0.5% beeswax and wherein said water phase is mixed and cooled and heated until homogeneous and an oil phase is prepared in the following proportions by weight; 4% raspberry seed oil and up to 1% hemp seed oil 1% Avacado oil, 1% mixture of rice bran oil (0.95%) and oryzinol (0.05%), plus 3% stearic acid, and 6.5% ethyl macadamiate wherein said oil phase is mixed and heated and cooled until homogenous and wherein said oil phase is added to said water phase followed by mixing and cooling and subsequent addition of 0.5% arabinogalactin 1% of glucose/glucose oxidase and 0.05 % of lactoperoxidase glucose, optionally fragrance followed by mixing until homogeneous said composition resulting in a stable product with an SPF value of greater than 30.
18. The composition of claim 1 , wherein biophotonic scanning methodology is employed to further develop said composition or other SPF formulations to provide optimal immuno- enhancing protection from free radical generation due to UV radiation from the sun including the use of carotenoids as free radical inhibiting agents wherein said biophotonic scanning methodology utilizes proper wavelengths emitted by laser or LED or other light sources and is specific to anti-oxidant wavelengths other than carotenoids.
19. A method for creating the composition of claim 1, the method comprising: a) creating an oil pre-mix comprising an oil and a dispersant; b) creating a pre-mix comprising aloe vera, inorganic sun-block agents, and a dispersant; c) optionally dispersing inorganic sun-block agents into an oil, homogenizing at a proper temperature while adding the contents of (a); d) creating an "oil phase" with the combined contents of (a) and (c), one or more oils (including essential oils), a dispersant, and an emollient; e) mixing until homogeneous while maintaining proper temperature; f) adding one or more SPF boosting oils and/or waxes, and/or an emulsifier and mixing until homogeneous; g) optionally adding hydrolyzed wheat protein and mixing until homogeneous; h) optionally addition one or more additional emulsifiers and mixing until homogeneous; i) optionally adding gamma oryzanol and mixing until homogeneous; j) optionally adding sun-block agents and mixing until homogeneous; k) adding sucrose stearate and mixing until homogeneous; 1) optionally adding an anti-oxidant and/or Vitamin E and mixing until homogeneous; m) preparing a separate "water phase" by homogenizing water, glycerin, the contents of phase (b) above, and optionally additional aloe vera, Carrageenan and arabinogalactin and mixing until homogeneous while maintaining proper temperature; n) slowly adding the water phase to the oil phase and mixing until homogeneous; o) optionally adding additional aloe vera and mixing until homogeneous; p) adding thickeners and mixing until homogeneous; q) optionally adding grapefruit seed extract and/or ascorbyl palmitate and mixing until homogeneous; r) optionally adding milk powder and mixing until homogeneous; s) adding preservative and mixing until homogeneous; t) optionally adding fragrance and mixing until homogeneous.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08726964A EP2134314A1 (en) | 2007-03-07 | 2008-03-19 | High spf transparent or translucent, cytoprotective, biodegradable, uv radiation resistant compositions |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90545307P | 2007-03-07 | 2007-03-07 | |
US60/905,453 | 2007-03-07 | ||
US91873107P | 2007-03-19 | 2007-03-19 | |
US60/918,731 | 2007-03-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008136889A1 true WO2008136889A1 (en) | 2008-11-13 |
Family
ID=39943804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/003580 WO2008136889A1 (en) | 2007-03-07 | 2008-03-19 | High spf transparent or translucent, cytoprotective, biodegradable, uv radiation resistant compositions |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2134314A1 (en) |
WO (1) | WO2008136889A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2971707A1 (en) * | 2011-02-18 | 2012-08-24 | Oreal | AQUEOUS COSMETIC COMPOSITION CONTAINING PARTICLES OF COMPOSITE MATERIAL AND GAMMA-ORYZANOL |
FR2975286A1 (en) * | 2011-05-20 | 2012-11-23 | Durance | Composition, useful for preventing/treating skin aging effects e.g. wrinkles and dryness, and skin firmness, and protecting human epidermis against attacks, comprises an oily extract rich in punicic acid associated with protein fraction |
KR20140093236A (en) * | 2011-11-17 | 2014-07-25 | 사까이가가꾸고오교가부시끼가이샤 | Surface-treated zinc oxide powder, anti-bacterial agent, and anti-bacterial composition |
EP2184052B1 (en) * | 2008-11-11 | 2017-09-20 | Kao Germany GmbH | Composition for hair |
PL422959A1 (en) * | 2017-09-25 | 2019-04-08 | Upadhyay Shakti | Method for activation of the cosmetic composition and the cosmetic composition |
CN112754947A (en) * | 2021-01-12 | 2021-05-07 | 上海百雀羚生物科技有限公司 | Protection system for efficiently neutralizing inorganic sunscreen agent to generate free radicals and application thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5824659A (en) * | 1996-09-04 | 1998-10-20 | Board Of Regents, The University Of Texas System | Cytoprotective oligosaccharide from Aloe preventing damage to the skin immune system by UV radiation |
KR0163942B1 (en) * | 1995-12-23 | 1998-12-01 | 이능희 | Method of pigment complex for make up cosmetics |
US5945090A (en) * | 1997-09-11 | 1999-08-31 | Randall Products International | Sunscreen preparation |
US20060233725A1 (en) * | 2001-08-09 | 2006-10-19 | Grune Guerry L | Non-Endocrine Disrupting Cytoprotective UV Radiation Resistant Substance |
-
2008
- 2008-03-19 EP EP08726964A patent/EP2134314A1/en not_active Withdrawn
- 2008-03-19 WO PCT/US2008/003580 patent/WO2008136889A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0163942B1 (en) * | 1995-12-23 | 1998-12-01 | 이능희 | Method of pigment complex for make up cosmetics |
US5824659A (en) * | 1996-09-04 | 1998-10-20 | Board Of Regents, The University Of Texas System | Cytoprotective oligosaccharide from Aloe preventing damage to the skin immune system by UV radiation |
US5945090A (en) * | 1997-09-11 | 1999-08-31 | Randall Products International | Sunscreen preparation |
US20060233725A1 (en) * | 2001-08-09 | 2006-10-19 | Grune Guerry L | Non-Endocrine Disrupting Cytoprotective UV Radiation Resistant Substance |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2184052B1 (en) * | 2008-11-11 | 2017-09-20 | Kao Germany GmbH | Composition for hair |
FR2971707A1 (en) * | 2011-02-18 | 2012-08-24 | Oreal | AQUEOUS COSMETIC COMPOSITION CONTAINING PARTICLES OF COMPOSITE MATERIAL AND GAMMA-ORYZANOL |
WO2012110303A3 (en) * | 2011-02-18 | 2013-01-10 | L'oreal | Aqueous cosmetic composition containing composite material particles and gamma-oryzanol |
FR2975286A1 (en) * | 2011-05-20 | 2012-11-23 | Durance | Composition, useful for preventing/treating skin aging effects e.g. wrinkles and dryness, and skin firmness, and protecting human epidermis against attacks, comprises an oily extract rich in punicic acid associated with protein fraction |
KR20140093236A (en) * | 2011-11-17 | 2014-07-25 | 사까이가가꾸고오교가부시끼가이샤 | Surface-treated zinc oxide powder, anti-bacterial agent, and anti-bacterial composition |
KR101967702B1 (en) | 2011-11-17 | 2019-04-11 | 사까이가가꾸고오교가부시끼가이샤 | Surface-treated zinc oxide powder, anti-bacterial agent, and anti-bacterial composition |
PL422959A1 (en) * | 2017-09-25 | 2019-04-08 | Upadhyay Shakti | Method for activation of the cosmetic composition and the cosmetic composition |
CN112754947A (en) * | 2021-01-12 | 2021-05-07 | 上海百雀羚生物科技有限公司 | Protection system for efficiently neutralizing inorganic sunscreen agent to generate free radicals and application thereof |
Also Published As
Publication number | Publication date |
---|---|
EP2134314A1 (en) | 2009-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9095522B2 (en) | High SPF transparent or translucent, cytoprotective, biodegradable, UV radiation resistant compositions | |
US20080219938A1 (en) | SPF compositions | |
US20080219939A1 (en) | Sunblock formulations | |
JP5222288B2 (en) | Cosmetic preparation containing skin care complex with anti-aging action | |
JP3596891B2 (en) | Sunscreen with plant extract | |
US20150110724A1 (en) | High SPF Transparent or Translucent Naturally Derived, Cytoprotective, UV Radiation Resistant Compositions | |
US20050196361A1 (en) | Non endocrine disrupting cytoprotective UV radiation resistant composition | |
JP2007533690A (en) | Beauty set to care for skin with tanning product set and tanning product | |
EP1804923B1 (en) | Moisture-regulating cosmetic | |
US6858200B2 (en) | Sunscreen formulations | |
WO2008136889A1 (en) | High spf transparent or translucent, cytoprotective, biodegradable, uv radiation resistant compositions | |
US11096886B2 (en) | Oat lipid extract | |
US9782610B2 (en) | Nontoxic, non-endocrine disrupting, cytoprotective, UV-radiation resistant sunblock compositions | |
EP3311792B1 (en) | Natural personal care compositions based on undecylenate ester | |
US20020012648A1 (en) | High phospholipid-containing dermatological compositions | |
KR102051058B1 (en) | Ascorbic acid disperstion and cosmetic composition containing the same | |
US8557264B2 (en) | Glycerine based jelly compositions | |
KR101085059B1 (en) | Skin whitening cosmetic composition comprising ascrobic acid stabilized by three layer | |
KR20210015907A (en) | Composition for skin cosmetics | |
KR20190142655A (en) | Cosmetic composition containg nanoemulsion encapsulated with 7-dehydrocholesterol, cholesterol and stearic acid in inner phase of hyaluronate-ceramide NP complex | |
EP1855635A1 (en) | Cosmetic preparation for extending tanning | |
US9913787B2 (en) | Glycerine based jelly compositions | |
RU2236842C1 (en) | "diamant" cream for eyelids | |
JP2016188190A (en) | Masking composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08726964 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008726964 Country of ref document: EP |